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ABSTRACT
The drug metabolising capability of the fetus has been investigated 
using freshly isolated and cultured fetal rat hepatocytes. Phase I 
metabolism has been investigated using 7-ethoxycoumarin and 
7-ethoxyresorufin as substrates and Phase II using 7-hydroxycoumarin. 
7-Ethoxycoumarin O-deethylase and 7-ethoxyresorufin 0-deethylase 
activities increased with increasing time in culture.
7-E tho xycoumar in O-deethylase activity in freshly isolated 
hepatocytes increased with increasing fetal age between 17 and 22 
days of gestation. a-Naphthoflavone inhibited 7-ethoxycoumarin 
O-deethylase activity poorly in the freshly isolated hepatocytes and 
strongly in the cultured hepatocytes. The pattern of metabolism -of 
some alkyl analogues of 7-ethoxyresorufin in cultured fetal 
hepatocytes suggested that a form of cytochrome P-450 was present 
resembling that form inducible in adult rat by 3-methylcholanthrene. 
Cytochrome P-450 concentration was very low in the freshly isolated 
fetal hepatocytes and increased approximately 2-fold after 48 hours 
of culture. Studies with inhibitors of RRA and protein synthesis 
indicated that translation was a prerequisite for the culture-induced 
increase in 7-ethoxycoumarin O-deethylase. Glucuronyl transferase 
and sulphotransferase showed increased 7-ethoxycoumarin O-deethylase 
activity in cultured fetal hepatocytes compared with the freshly 
isolated cells. This increase was considerably less that that seen 
for phase I metabolism.
ii
7“Ethoxycôumarin O-deethylase activity in the fetal rat was very 
susceptible t© induction by 5-methylcholanthrene, Arochlor and 
P-naphthoflavone. This induction was reflected in an increased 
inhibition by a-naphthoflavone and by a large increase in the amount 
of material immunoprecipitated by an anti-cytochrome P-448 
immunoglobulin in an Ouchterlony double diffusion assay and in 
immunochemically stained sections of fetal liver. Petal rat 
7-ethoxycoumarin O-deethylase activity appeared unresponsive to 
induction by phenobarbitone.
Ill
ACKNOWLEDGEMENTS
I should like to express my gratitude to my supervisor. Dr Laurie
King, for his help and interest in this project.
I wish to thank Dr Diane Benford for her much needed help, advice and 
patience throughout the last three years, especially during the early 
stages of the project when problems were numerous.
I should like to express my appreciation to Drs Hilary Masson and 
Satinder Bains for their help with the polyacrylamide gel 
electrophoresis and immunology studies and to Dr Hilary Masson and Mr 
Richard Makowski for their kind gifts of antisera.
Much thanks is due to Mr Chris Powell for his help in preparing the 
immunocytochemically stained sections and for excellent photography.
I should like to thank my many colleagues, both staff and student, in 
the Biochemistry Department for their willingness to help me whenever 
possible.
Finally, I am indebted to my husband, Chris, who has helped me in
numerous ways over the past three years and has always shown great
patience and enduring support.
IV
CONTENTS
Abstract i
Acknowledgements iii
Table of Contents iv
Terminology vii
CHAPTER ONE - INTRODUCTION 1
1.1 General Introduction to Developmental Toxicology 21.1.1 Human Perinatal Mortality and Abnormality 2
1.1.2 The Nature of Petal Toxicity 3
1.1.3 Causes of Congenital Abnormalities 71.1.4 Exposure of the Petus to Xenobiotics 7
1.2 Xenobiotic Metabolism in the fetus 91.2.1 Introduction 9
1.2.2 Drug Disposition in the Petus 101.2.3 Studies on Phase I Metabolism 121.2.4 Studies on Phase II Metabolism 181.2.5 Induction Studies in the Petus 231.2.6 Developmental Studies 24
1.3 Possible Involvement of Drug Metabolism in Developmental Toxicology 25
1.3.1 Petal Toxicity 25
1.3.2 Transplacental Carcinogenesis 27
1.4 Methods for the Assessment of Petal Drug Metabolism 29
1.5 Aims of the Study 3I
CHAPTER TWO - MATERIALS AND METHODS 332.1 Animals 342.2 Materials 342.3 Preparation of Petal Rat Hepatocytes 352.4 Culture of Petal Rat Hepatocytes 362.5 Drug Metabolism Studies in Preshly Isolated Cells 372.6 Drug Metabolism Studies in Cultured Cells 37
2.7 Determination of 7-Ethoxycoumarin 0-Deethylase Activity 37
2.8 Determination of 7-Alkoxyresorufin 0-Deethylase Activity 38
2.9 Determination of Glucuronyl Transferase and Sulphotranferase Activity 39
2.10 Preparation of Microsomal Fractions 40
2.11 Determination of Cytochrome P-450 41
2.12 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis 42
2.13 Ouchterlony Double Diffusion Analysis 432.14 Estimation of Protein 442.15 Haematoxylin and Eosin Staining of Cultured Cells 44
2.16 Peroxidase-antiperoxidase Immunological Staining of Petal Tissues44
CHAPTER THREE - DRUG METABOLISM IN FRESH AND CULTURED
FETAL HEPATOCYTES 463.1 Histological Assessment of Fresh and Cultured Cells 4-7
3.1-1 Results 47
3.2 7-Ethoxycoumarin 0-Deethylase Activity in Fresh and Cultured
Petal Hepatocytes on days 16-22 of gestation 503.2.1 Introduction 50
3.2.2 Results 51
3.3 Studies on the Inhibition of 7-Ethoxycoumarin 0-Deethylase 623.3«1 Introduction 623.3*2 Results 65
3.4 7-Ethoxy-resorufin 0-Deethylase Activity in Fresh and Cultured Petal Hepatocytes on Day 20 of Gestation 69
3.4.1 Introduction 693.4.2 Results 70
3.5 Metabolism of Some Alkyl Analogues of 7-Ethoxyresorufin 723.5*1 Introduction 723.5.2 Results 72
3.6 Glucuronic Acid and Sulphuric Acid Conjugation of 7-Hydroxycoumarin 
in Fresh and Cultured Petal Hepatocytes on Day 20 of Gestation 753.6.1 Introduction 753.6.2 Results 75
3.7 Measurement of Cytochrome P-450 in Fresh and Cultured Hepatocytes from Fetuses of 20 Days Gestational Age 79
3.7.1 Introduction 793.7.2 Results 79
3.8 The Effect of Actinomycin D and Cycloheximide on 7-Ethoxycoumarin 0-Deethylase Activity in Cultured Petal Hepatocytes Prom Fetuses of
20 Days Gestational Age 81
3.8.1 Introduction 813.8.2 Results 81
3.9 Polyacrylamide Gel Electrophoresis of Microsomal Fractions from Preshly Isolated and Cultured Petal and Adult Hepatocytes 833.9.1 Introduction 833.9.2 Results 83
3.10 Immunocytochemical Staining of Preshly Isolated and Cultured Petal Hepatocytes with Anti-cytochrome P-450 andAnti-cytochrome P-448 873.10.1 Introduction 873.10.2 Results 88
3.11 The Effect of Insulin on Cultured Petal Hepatocytes 93
3.11.1 Introduction 933 .11.2 Results 94
VI
3.12 Discussion 96
3.12.1 Histological Assessment of Fresh and Cultured Fetal Hepatocytes963.12.2 The Effect of Culture on Phase I and Phase II Metabolism 96
5.12.3 The Effect of Fetal Age on 7-Ethoxycoumarin 0-Deethylase 
Activity in Fresh and Cultured Fetal Hepatocytes 103
3.12.4 Inhibition of 7-Ethoxycoumarin 0-Deethylase Activity 1053.12.5 The Effect of Insulin on Cultured Fetal Hepatocytes 106
CHAPTER FOUR - INDUCTION STUDIES 1084.1 Introduction to Induction Studies 1094.2 Results of Induction Studies 111
4.3 Discussion 128
CHAPTER FIVE - FINAL DISCUSSION 1365.1 The Effects of Culture on Hepatocyte Drug Metabolising Activity:A Comparison of Fetal and Adult Hepatocytes 1375.2'The Usefulness of Freshly Isolated and Cultured Fetal Hepatocytesfor Drug Metabolism Studies 1405.3 The Nature of Fetal Drug Metabolism 141
5.4 Future Work 143
REFERENCES 144
vil
TERMINOLOGY
Currently, nomenclature concerning the cytochrome P-450 drug metabolising 
enzymes is confused. Therefore, for the purpose of this thesis the 
following conventions have been used:
Cytochrome P-450 - all cytochrome P-450 isoenzymes
P-450 type of cytochrome - that type induced by phenobarbitone and
having a reduced CO-binding maximum at 
450nm
P-448 type of cytochrome - that type induced by polycyclic aromatic
hydrocarbons, inhibited by a-naphthoflavone 
and having a reduced CO-binding maximum 
at 448nm
For the immunology study (See Chapter 4) the nature of the purified 
cytochromes used are further described.
Nebert and Negeishi (1982) describe more fully the nature of some of the 
currently isolated cytochrome P-450 isoenzymes
CHAPTER ONE : INTRODUCTION
1.1 General Introduction to Developmental Toxicology
1.1.1 Human Perinatal Mortality and Abnormality
The Department of Health and Social Security Report on the State of 
the Public Health for 1980 reported 4,523 still births (7.3 per 1000
total births). In addition to this 3,793 infants died within the
first week after birth (6.1 per 1000 live births) and a further 2,706 
infants died between one week and one year after birth (4.4 per 1000 
live births).
In the same year 12,704 babies were born alive with a congenital
malformation which was discovered within seven days of birth. This
represents 19.9 per 1000 live births. These figures do not include 
congenital abnormalities which are not apparent in early neonatal 
life e.g. visual or hearing defects, mental retardation or metabolic 
abnormalities.
These figures represent a serious problem. Many children with 
abnormalities acquired in utero survive with long term handicaps 
requiring prolonged medical treatment and attendance at special 
schools or institutional care. This places enormous emotional stress 
on the families of such children. Additionally, the House of Commons 
Second Report from the Social Services Committee on Perinatal and 
Neonatal Mortality expressed concern over the total cost to the 
country of caring for perinatally handicapped persons. Clearly, 
research is required to try and improve the current status of 
perinatal care. To increase our understanding of perinatal 
abnormality and mortality, investigations of the underlying causes 
and the biochemical mechanisms leading to abnormality are required.
1.1.2 The Nature of Fetal Toxicity-
Fetal toxicity'may he defined as any deleterious effect sustained 
during development in utero as a result of exposure to a foreign 
compound. The deleterious effect may he observable at birth or may 
be latent and only manifested during or after maturation. Since the 
fetus appears to be particularly susceptible to damage during its 
development, little or no toxicity may be seen in the maternal 
system. The toxicity may manifest itself in a number of different 
ways. These will depend on the developmental stage of the fetus on 
exposure to the toxicant, on the route of exposure and on the 
severity and duration of the exposure.
a. General Toxicity
This occurs when the effect seen in the fetus is an extension of the 
toxicity observed in the maternal system. Fetal toxicity may be
observed at a lower dose than that required to elicit a toxic 
response in the maternal system. Examples of this are the fetal
lactacidosis seen on maternal administration of phenformin and the 
fetal thrombocytopenia seen on maternal administration of tolbutamide 
(Apgar, 1964).
b. Fetal Death
This may be a response to the development of gross malformations or 
may be a result of gross systemic fetal toxicity. It can occur 
before or after implantation. In most laboratory animals, fetal 
death results in resorption of the fetus. In primates, however, 
pre-implantation fetal death results in resorption of the embryo but 
after implantation fetal death results in spontaneous abortion or 
still birth. There is evidence suggesting that bis-hydroxycoumarin
and chloramphenicol may he associated with human fetal death (Apgar,
1964).
c. Growth Retardation
Growth retardation may occur alone or in conjunction with other forms 
of fetal toxicity. The growth retardation may be reversible or 
irreversible postnatally and may be a general effect giving rise to a 
small fetus or may occur in specific areas of the fetus giving rise 
to abnormalities.
Human fetal growth retardation has been shown to occur as a result of 
cigarette smoking during pregnancy (Abel, 1980),
d. Teratogenesis
This is defined as the production of a physical malformation e.g. 
limb defect, heart defect, abnormal genitalia. This type of toxicity 
can only be caused during the period of organogenesis. Once all the 
structures of the fetus are complete a teratogenic effect can no 
longer occur. Examples of chemically induced teratogenesis are 
phocomelia produced by thalidomide in man (Kajii et al., 1973) and 
cleft palate seen in the mouse on phenytoin administration (Hanson 
and Smith, 1975; Harbison and Becker, 1970).
e. Behavioural Defects
Behavioural parameters, which can be affected by in utero toxicity, 
include motor ability, sociability, sensory functions and learning 
ability. Subtle changes in these parameters are often difficult to 
observe in experimental animals. Behavioural defects may arise from 
biochemical disturbances within the nervous system or from either
macro or micro lesions of the neural tissue. Examples of compounds 
which have been observed to cause behavioural abnormalities when 
administered transplacentally include alcohol, which has been shown 
to cause mental retardation in human infants (Clarren and Smith, 
1978), methyl mercury which also produces behavioural abnormalities 
in human infants (Takenchi et al., 1979) and narcotics which have 
been observed to affect behaviour in the rat (Lasky et al., 1977; 
Kirby, 1979).
f. Functional Deficit
This is the induction of a non-structural defect in a fetus as the 
result of in utero exposure to a foreign agent. It may be detectable 
at birth or may be latent until adulthood. The defect may be a 
biochemical disturbance e.g. enzyme deficiency, hormonal disturbance
e.g. hypothyroidism, or a loss of a specific function e.g. 
blindness and deafness. Examples of compounds causing functional 
deficits on transplacental administration include methyl mercury 
which decreases neonatal glucose 6-phosphatase activity (Snell, 
1982), antithyroid drugs giving rise to hypothyroidism (Schardein, 
1976) and antihistamines which can induce infertility (Harbison, 
1980).
g. Transplacental Carcinogenesis
Transplacental carcinogenesis occurs when a neonate or adult develops 
a tumour as a result of in utero exposure to a carcinogen. 
Generally, a much lower dose is required to produce a tumour than if 
the carcinogen is administered to an adult. Examples of compounds 
inducing transplacental carcinogenesis are N-ethyl-N'-nitrosourea 
which produces tumours of the central nervous system in rats
(ivankovic and Druckrey, 1968) and diethylstilboestrol which produces 
vaginal adenocarcinoma in young human females (Herbst et al., 1978).
1.1.3 Causes of Congenital Abnormalities
Wilson (1973) investigated the causes of human developmental 
abnormality. He estimated that 20 - 25 percent of all congenital
abnormalities are caused by genetic abberations. Maternal imbalance 
(e.g. thyroid disorders, diabetes, phenylketonuria) accounts for 
another 1 - 2 percent. Radiation appears to be a causative factor in 
less than 1 percent of cases with maternal infection giving rise to 
only another 2 - 3  percent. In only 2 - 3  percent of cases have 
drugs been shown to be the causative factor. Thus, in 65 -70 percent 
of all cases of congenital abnormality the cause is unknown.
These cases may also result from genetic factors, maternal metabolic 
imbalance, infection, radiation or foreign compounds but be 
unrecognised or may be a result of different unidentified factors. 
Many drugs and environmental chemicals are suspected of being human 
teratogens but epidemiological studies have been inadequate in 
assessing their contribution to the production of congenital 
abnormalities.
1.1.4 Exposure of the Fetus to Xenobiotics
During its development, the human fetus may be exposed to a large 
number of chemical agents. These include drugs, food additives, 
tobacco, alcohol, caffeine and environmental pollutants.
Forfar and Nelson (1973) conducted a study of 911 mothers, selected 
at random in the United States and found that 82 percent were 
prescribed drugs, during pregnancy, excluding prescriptions for iron. 
On average each woman was prescribed four different types of drugs 
throughout the pregnancy. In addition to prescribed drugs, 65
percent of these pregnant women took self-prescribed compounds with 
the average taken during pregnancy being 1.5 different types of drug. 
The duration of therapy varied from 10-125 days. The drugs taken 
during pregnancy included analgesics, barbiturates, diuretics, 
antihistamines, tranquilisers, hypnotics, antiemetics and appetite 
suppressants. Of the total number of pregnant women studied, 54 
percent took aspirin at some stage during pregnancy, 3 percent took 
paracetamol, 2 percent amylobarbital and 11 percent phénobarbital.
Sullivan and Barlow (l979) observed that in general the working 
environment contains higher levels of foreign chemicals than the 
non-working environment. Since in the United Kingdom 36 percent of 
the workforce is female, there is an enormous potential for exposure 
of pregnant women to industrial chemicals.
Many of the chemicals that the human fetus is exposed to, appear to 
have the potential to damage it. Abel (1980), in a review of the 
literature, concluded that smoking during pregnancy is associated 
with pre- and post-natal growth retardation, increased risk of 
perinatal death and adverse effects on the behaviour of the 
offspring. A number of drugs have been identified as being positive 
human teratogens. These include thalidomide, some steroids, 
aminopterin, methotrexate and certain antithyroid drugs. 
Additionally, there are a large number of drugs for which current 
evidence is equivocal. These include some frequently used and 
commonly prescribed drugs e.g. many anticonvulsants, oral 
hypoglycaemics and certain antibiotics. Barlow and Sullivan (1982) 
studied data on the fetal toxicity to various laboratory animals of 
forty eight common industrial chemicals. They found that carbon
monoxide, formaldehyde, toluene and vinyl chloride caused a decrease 
in fetal growth; chloroform, dichloromethane and xylene were 
fetotoxic; henzo(a)pyrene, chloroprene and acrylonitrile were 
teratogenic; anaesthetic gases caused spontaneous abortions and 
benzo(a)pyrene and vinyl chloride were transplacental carcinogens. 
These authors concluded that there was inadequate data to assess 
whether these chemicals produce similar effects in the human fetus.
1.2 Xenobiotic Metabolism in the fetus
1.2.1 Introduction
In 1959, Dutton observed the glucuronidation of o-aminophenol in 
human fetal hepatic and renal tissues. More glucuronidation was 
observed in kidney than liver but activities observed were very low 
in comparison with those measured in adult human liver. A number of 
subsequent studies were in agreement with this (Weiss et al., 1960).
Pomp et al. (1969) were unable to detect any déméthylation of 
p-nitroanisole and N-methyl p-nitroaniline in human fetal liver. 
This was in agreement with the results of studies by Jondorf et al. 
(1958) who were unable to detect metabolism of aminopyrine, 
phenacetin and hexobarbital by neonatal mouse liver homogenate and 
neonatal guinea pig hepatic microsomes. The conclusion that was 
generally drawn by the investigators at this time was that perinatal 
drug metabolism was negligible in all species and was not a 
significant consideration in fetal pharmacokinetics and developmental 
toxicity (Netter, 1971).
However, as a result of studies carried out in the last decade, it 
has been shown that such a generalisation is not valid and that the 
fetuses of a number of animals, depending on age and species, are
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capable of carrying out a variety of drug biotransformations. There 
appear to be two reasons mainly responsible for this. Firstly, over 
the last decade methodology has improved with the introduction of 
more sensitive assays. This has enabled low drug metabolising 
activity to be detected. Secondly, improvements have been made in 
the preparation of fetal liver microsomes (Ackermann et al., 1972).
Considerably more work has been carried out on the cytochrome 
P450-dependent monooxygenation of foreign compounds in the fetus than 
on other types of reaction. However, there are still large gaps in 
our knowledge of this area including the nature of the fetal 
cytochrome(s) P450, the nature of the induction of metabolism and 
patterns of development of the drug metabolising enzymes. Still less 
is known about cytochrome P450-independent metabolism. Of the phase 
II reactions glucuronic acid conjugation has been most thoroughly 
investigated in the fetus, however, a clear picture, with respect to 
enzyme heterogeneity and developmental patterns, of fetal glucuronic 
acid conjugation in laboratory animals and man is still not 
available. Information on other phase II reactions in the fetus is 
at best incomplete.
1.2.2 Drug Disposition in the Fetus
Xenobiotics reach the fetus as a result of transfer across the 
placenta. Most small molecules are able to cross the placenta. The 
rate of placental transfer of xenobiotics appears to be largely 
dependent on lipophilicity (Dutton, 1982). The rate of transfer may 
also be influenced by the rate of maternal blood flow and by maternal 
plasma protein binding of the compound (Green et al., 1979). Having 
crossed the placenta, xenobiotics may be distributed throughout the
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fetal tissues. The fetal blood brain barrier is poorly developed and 
salicylic acid and diphenyl hydantoin show a high uptake by the fetal 
neuroepithelium (Ullberg et al., 1982). The high incidence of 
central nervous system malformations seen in the fetal rat may be 
related to the poorly developed blood brain barrier.
There are a number of possible ways in which the fetus may deal with 
foreign chemicals. The unchanged drug may pass back across the 
placenta for elimination by the maternal system. This will occur 
when the concentration of unchanged drug in the fetal circulation 
exceeds that in the maternal circulation giving rise to a 
concentration gradient across the placenta. Xenobiotics may be 
sequestered and accumulate in the fetal tissues. Examples of this 
are tetracycline which accumulates in the fetal skeleton (Blomquist 
and Hanngren, 1966), diethylnitrosamine which accumulates in fetal 
mouse bronchial mucosa in late gestation (Brittebo et al., 1981) and 
phenothiazine derivatives which bind to the fetal melanin-containing 
tissues of the eye, inner ear and skin (Lindquist and Ullberg, 1972). 
It has been suggested that the metabolism of drugs by fetal tissues 
may give rise to more polar metabolites, diminishing the rate of 
transfer back across the placenta to the maternal system. While 
biliary excretion of unchanged drugs would result in resorption in 
the intestine, setting up an enterohepatic circulation, biliary 
excretion of a conjugated compound could result in its accumulation 
in the non-functional fetal intestine. This has been shown to occur 
in the fetal rat for the glucuronic acid conjugate of 
diethylstilboestrol (McLachlan, 1977; Miller et al., 1982) and for 
glucuronides of certain hydroxylated metabolites of the chlorinated 
biphenyls (Lucier et al.,1978).
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1.2.3 Studies on Phase I Metaholism
Table 1.1 lists a number of studies of phase I metabolism in hepatic 
tissue from fetal mouse, rat, hamster, rabbit, guinea pig and 
non-human primates. In all cases, the activity of the oxidative 
enzymes are much lower than that seen in the adult. Generally, there 
is an increase in drug metabolising activity with increased 
gestational age. Investigations of drug metabolism during early 
development are difficult due to the limited amount of tissue 
available. In most studies, no metabolism has been detected before 
15 days of gestation in the fetal rat (Juchau et al., 1982). It has 
been suggested that this is due to the lack of functional 
parenchymatous tissue in the fetus prior to this gestational age.
However, Galloway et al. (1980) detected benzo(a)pyrene-induced 
sister chromatid exchange in post-implantation-cultured mouse embryos 
at day 7.5 of gestation, suggesting the presence of enzymes capable 
of metabolising benzo(a)pyrene to active metabolites. Filler and Lew 
(1981) cultured mouse embryos and found very low levels of 
benzo(a)pyrene metabolising activity present at the blastocyst stage 
of development.
There is very little information on extrahepatic fetal metabolism in 
laboratory animals. Rouet et al. (1981) found oxidative products of 
benzo(a)pyrene metabolism in liver, lungs and brain of rat and mouse 
in late gestation. No other information is available in this area.
A large number of studies of oxidative metabolism in the fetal human 
liver have been made. Table 1.2 lists some of these. Generally, 
higher levels of activity have been observed in fetal human compared
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to fetal laboratory animals. As seen with laboratory animals the 
rate of metabolism generally increases with increasing fetal age.
However, this rate of increase diminishes in the third trimester and 
adult levels are not attained until some time post-natally. There is 
a large variation in the observed rate of oxidative metabolism 
between different substrates. This may be due to variation in 
experimental technique between investigators, to intrinsic
differences in the ability of the fetus to metabolise various 
substrates, or to a combination of both of these factors. 
Experimental variation may arise as a result of the technique used 
for termination of pregnancy, variation in the exposure of the 
pregnant mother to inducers of drug metabolism or in the nature of 
the methods used for estimation of drug metabolising activity (see 
section 1.4).
In addition to hepatic oxidative metabolism, the human fetus has the 
capacity for extrahepatic oxidative metabolism. The fetal human
adrenal gland appears to have particularly high metabolic activity. 
However, the monooxygenase system in the fetal human adrenal gland 
seems to differ from the hepatic system. The adrenal monooxygenase 
oxidises fewer substrates than the hepatic enzyme e.g. aminopyrine 
is metabolised by the fetal hepatic but not adrenal enzyme (Juchau et 
al., I98O). This difference may be related to the possible role of 
the fetal adrenal gland in steroid metabolism. Juchau et al. (1978) 
reported that the human fetal kidney and lung can oxidise 
7,12-dimethylbenzo(a)anthracene to 7,1 2-dihydroxymethyl-
benzo(a)anthracene.
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Thus, fetal human and non-human primate oxidative metabolism appears 
in early gestation whereas oxidative metabolism appears late in the 
gestation of laboratory animals. This difference may be real or 
apparent. Table 1.3 shows the developmental status of man and some 
laboratory animals at different gestational ages. From the table it 
can be seen that mouse, hamster, rat, rabbit and guinea pig are born 
soon after embryogenesis is completed but the human and non-human 
primate are born much later than this, at a considerably greater 
stage of maturity. This could be responsible for the differences 
seen in the gestational age of onset of drug metabolism.
The human fetus is usually exposed to a much greater spectrum of 
xenobiotics than are fetal laboratory animals e.g. cigarette smoke, 
alcohol, drugs, and food additives (Pelkonen et al., 1980). This may 
also contribute to the observed differences seen in the onset and 
extent of drug metabolism in the human fetus and fetal laboratory 
animals.
TABLE 1.1 FETAL HEPATIC HOKOOXYGENASE ACTIVITY IN VARIOUS ANIMAL SPECIES 15
SPECIES
rat
METABOLIC REACTION TYPE OF LIVER AGE OF FETUS ACTIVITY AS PERCENTAGE REFERENCE
benzo(a)pyrene
hydroxylation
PREPARATION
A
(days)
17-20
OF ADULT
0.7
dimethylnitrosamine
N-demethylation
18 4.1
hamster henzo(a)pyrene
hydroxylation
14 5.8
guinea pig henzo(a)pyrene 
hydroxylation
p-chloronitromethyl
aniline
N-demethylation
33
43
53
63
43
53
63
0.37 
0.78 
1.03 
4.31
non-deteotable
1.5
12.5
rabbit benzo(a)pyrene
hydroxylation
aminopyrine
déméthylation
p-nitroanisole
déméthylation
19
29
19
29
30
non-detectable
3
non-detectable
50
30
pig hexobarbital
hydroxylation
100-114 0-4
stumptailed benzphetamine 
macaque déméthylation
ethylmorphine 
N-demethylation
120
160
1.5-3
3-5
pigtail benzo(a)pyrene
monkey hydroxylation
2-acetaminofluorene
hydroxylation
80-150
80-150
0.9
2 -1 0
REFERENCES: 1. Oesch (1957b), 2. Jannetti and Anderson (1981), 3* Wang et al. (1974), 
4. Kuenzig et al. (1974), 5» Vainio (1975), 6. Rane et al. (1973b),
7. Short and Davis (1970), 8. Dvorchik et al. (1976), 9. Juchau et al. (1975).
LIVER PREPARATIONS : A - 105,000g pellet, B - 800g supernatant, C - 12,000g supernatant. 
D - 78,000g pellet, E - whole homogenate.
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1.2,4 Studies on Phase II Metabolism
a. Glucuronic Acid Conjugation
The fetal development of glucuronyl transferase activity appears to 
be dependent on the species and even strain and on the nature of the 
substrate. This may be due to species variation in the onset of 
development of the enzyme and also to the multiplicity of glucuronyl 
transferases (Dutton, 1978). Burchell (1974) found that the ASH/TO 
strain of mice, at day 14 of gestation showed very high glucuronyl 
transferase activity towards o-aminophenol but less than one percent 
of the adult activity towards oestriol.
The substrate-dependent heterogeneity of glucuronyl transferase in 
fetal rat liver has been investigated (Wishart and Dutton, 1978; 
Wishart and Campbell, 1979). They have shown that there are two 
clusters of glucuronyl transferases, one that appears at about day 16 
of gestation and surges to adult values by day 20 and is known as the 
fetal cluster and one that achieves less than ten percent adult 
values by day 20 but surges to adult values after birth and is known 
as the neonatal cluster. There is little overlap in the substrates 
for each of these clusters and the classes into which each substrate 
falls seems to be governed by the three-dimensional shape of the 
molecule.
A number of investigations of glucuronyl transferase activity in 
human fetuses have been carried out. Glucuronyl transferase activity 
appears to be low or absent with respect to p-nitrophenol, 1-naphthol 
(Pane et al., 1973a) and paracetamol at 19 and 22 weeks of gestation 
(Rollins et al., 1979). However, Burchell (1974) reported detectable 
glucuronyl transferase activity in fetal human liver preparations at
19
20 weeks of gestation with 4-methylumbelliferone as substrate and 
Guillouzo et al. (1982) observed glucuronidation of guanfacine in 
hepatocytes prepared from a 30 week old fetus. Additionally, large 
amounts of glucuronic acid conjugates of steroids have been found in 
fetal human tissues and in fetal bile and amniotic fluid (Pelkonen et 
al., 1980). Although fetal human glucuronyl transferase activity 
appears to be dependent on the nature of the substrate, there is 
currently insufficient evidence to suggest the presence of fetal and 
neonatal clusters of glucuronyl transferases.
b. Sulphuric Acid Conjugation
The perinatal development of sulphate conjugation has received less 
attention than the development of glucuronide conjugation. Namkung 
et al. (1977) carried out a study of sulphate conjugation in a 
number of tissues taken from fetal human (10 - 16 weeks of
gestation), fetal monkey (25 weeks of gestation) and fetal guinea pig 
(57 “ 62 days of gestation). There was no pattern apparent in the 
development of the sulphotransferase activity, either as a function 
of organ specificity or with time. Sulphotransferase activity was 
also dependent on the substrate studied. Petal human adrenal gland 
showed a higher specific activity than any other organ whereas in the 
guinea pig fetus, most metabolism was seen in the kidney.
Wengle (1966) demonstrated that in human, the sulphotransferase 
enzymes necessary for steroid conjugation appear very early in fetal 
life, with the oestrogen sulphotransferase activity nearly as high as 
in adults in late fetal human liver. Rollins et al. (1979) detected 
sulphate conjugation of paracetamol in human fetal liver cells at 19
20
and 22 weeks of gestation.
0. Amino Acid Conjugation
Irjala (1972) reported that the rate of conjugation of glycine with 
salicylate occurred approximately as rapidly in fetal human liver 
preparations as in the corresponding adult tissues. This observation 
has never been confirmed, but Levy (1975) reported that human 
neonates excreted relatively more salicyl glycine than did adults. 
Bile acid conjugation in organ culture of fetal human liver has been 
investigated by Haber (1978). He found that primary bile acid was 
conjugated with taurine and glycine. Taurine conjugation 
predominated. Supplementation of the medium with taurine resulted in 
enhanced taurocholate formation with complete inhibition of 
glycocholate synthesis, suggesting that there is only one acyl 
transferase for both taurine and glycine.
Brandt (1966), however, using benzoyl CoA as substrate found that 
glycine conjugation occurred only as traces in the fetus and neonate 
of rat. There is no other information in the literature concerning 
fetal rat glycine conjugation.
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d. Glutathione Conjugation
James et al. (1977) measured glutathione 8-epoxide transferase and 
glutathione 8-aryl transferase activity in fetal guinea pig and fetal 
rabbit tissues. Liver did not show any glutathione 8-transferase 
activity in the fetal rabbit until birth. However, at around days 
17-18 of gestation, the fetal rabbit showed glutathione 8-transferase 
activity in the intestine, lung and kidney of around 100, 70 and 50 
percent of adult values respectively. Glutathione 8-transferase 
activity in the fetal guinea pig was measured from day 45-68 of 
gestation. Activity in the liver rose from 5-10 percent of adult
activity at birth, in the intestine, 40-60 percent, in the kidney,
20-50 percent and in the lung 100 percent of adult activity was seen
at day 54. Thus, the rates at which adult values of these enzyme 
activities are reached differ in hepatic and extrahepatic tissues.
Chasseaud (1973) reported that glutathione S-transferase activities 
in fetal human livers were approximately equal to those measured in 
human adult livers. Juchau and Namlcung (1974) also found high levels 
of glutathione S-transferase in fetal human liver. Mukhtar et al. 
(1981) found that human fetal liver, kidney, lung, muscle, heart, 
adrenal gland, pancreas and stomach possessed higher enzyme
activities than the corresponding adult tissues.
e. Méthylation
Prenatal catechol-o-methyl transferase activity appears to be low in 
fetal hepatic tissues of rats and humans with endogenous substrates 
such as adrenaline and noradrenaline (Agathopoulous et al., 1971; 
Guldbert and Marsden, 1975). There is little data on the prenatal 
méthylation of xenobiotics. Aranda et al. (1974) investigated the
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metabolism of theophylline in cultured explants of fetal human liver 
taken at weeks 12-20 of gestation. The explants methylated the 
theophylline to caffeine. Human adults demethylate and oxidise 
theophylline to monomethylxanthines and methyluric acid. Thus, the 
metabolism of theophylline may be unique to the fetal stage. This 
suggests that fetal tissues may contain enzyme systems that are not 
expressed during post natal life.
f. Epoxide Hydration
Epoxide hydrolase activity was measured in fetal rat liver by Oesch 
(1975a). A trace amount of epoxide hydration was measurable in the 
15 day old rat fetus after which there was a steady rise in activity 
up until day 20. Adult values of epoxide hydrolase activity were not 
given for comparison.
James et al. (1977) measured epoxide hydrolase activity in fetal 
tissues of guinea pig and rabbit. Guinea pig showed detectable 
metabolism in only the lung during the late fetal period. However, 
low levels of metabolism were seen in the rabbit liver, lung, kidney 
and intestine in the late fetal period.
Juchau and Namkung (1974) studied epoxide hydrolase in human and 
monkey fetal microsomes. This study reported that several fetal 
tissues from human and subhuman primates demonstrated epoxide 
hydrolase activities greater than those measured in adult rat and 
rabbit livers. Human fetal kidneys showed that highest epoxide 
hydrolase activity.
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1.2.5 Induction Studies in the Fetus
Very much more information is available on induction of drug 
metabolising enzymes in laboratory animals than on human fetal 
induction. In humans, the inducing stimulus is very seldom, if ever, 
maximal and it is very difficult to expose a human fetus to one 
inducing stimulus only. In animal experiments, larger doses may be 
used and controlled exposure conditions maintained.
Much controversy exists on the inducibility of fetal drug metabolism. 
The inducibility of fetal drug metabolising activity appears to be a 
function of the developmental status of the fetus, the tissue 
studied, the nature of the inducer and the nature of the substrate 
and metabolic pathway chosen for study. Inducers of drug metabolism 
may be broadly classed as those inducing the P-450 type of cytochrome 
and those inducing the P-448 type of cytochrome. The former group 
includes phenobarbitone, the latter, polycyclic hydrocarbons such as 
3-methylcholanthrene, benzo(a)pyrene, 2,3,7,8-tetrachloro-
dibenzo-p-dioxin and polychlorinated biphenyls.
In general, the cytochrome P-448 type of inducers are the most potent 
inducers during the fetal period, whereas phenobarbitone or alcohol 
hardly induce oxidative metabolism at all (Guenther and Mannering, 
1977; Cresteil et al., 1979). Schlede and Marker (1972) found that 
the earliest occasion on which aryl hydrocarbon hydroxylase could be 
induced by benzo(a)pyrene in the fetal rat was day 15 of gestation. 
Guenther and Mannering (1977) also demonstrated that simultaneous 
treatment with phenobarbitone and 3-methylcholanthrene induces 
oxidative metabolism in fetal rat liver more than can be expected on 
the basis of their separate effects.
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In human, some studies have indicated that if certain drugs or 
alcohol are administered to pregnant mothers for long periods and in 
large doses, drug metabolism in the fetal human liver may be induced 
during the first half of pregnancy (Pelkonen et al., 1973a). In 
addition, human fetal hepatocytes in culture (prepared from fetuses 
of 9-14 weeks of age) showed a one to five times induction on 
exposure to benzo(a)anthracene and 3-methylcholanthrene but not with 
benzo(a)pyrene (Pelkonen et al., 1975).
1.2.6 Developmental Studies
A number of studies have shown that many enzyme activities have 
distinct patterns of development in the fetus (Greengard, 1971; 
Snell, 1982). This has been shown to be the case for a number of 
drug metabolising enzymes. It seems likely that the emergence and 
disappearance of different enzymes are regulated quite independently.
Henderson (l978) found that the post-natal development of oxidative 
N-demethylation of N-methylamphetamine did not follow that of 
oxidative N-demethylation of N-N'-dimethylamphetamine in fetal rat 
liver, suggesting that multiple forms of N-demethylating enzymes 
exist which develop independently from each other. Multiple forms of 
glucuronyl transferase, developing independently have also been 
demonstrated as discussed in section 1.2.4.
A number of substances have been implicated as controlling factors in 
the development of fetal xenobiotic metabolising enzymes. These 
include progesterone (Kardish and Feuer, 1972), androgens (Pedersen 
et al., 1974), glucocorticoids (Wishart and Dutton, 1976), fetal 
serum inhibitor (Ko et al., 1967) and birth (Leakey and Fonts, 1979).
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There may he an interaction of more than one factor and different 
factors may control the development of different enzymes.
Studies carried out by Wishart and Dutton (1977) seem to suggest that 
glucocorticoids are responsible for the triggering of the development 
of the late fetal cluster of glucuronyl transferases seen in the 
fetal rat. The neonatal cluster of glucuronyl transferases appears 
to require a different or additional, as yet unidentified, stimulus 
for its appearance,
1.3 Possible Involvement of Drug Metabolism in Developmental 
Toxicology
Drug metabolism is an important consideration in assessing the 
toxicity of foreign compounds. Metabolism of a xenobiotic can lead 
to detoxification or to an increase in toxicity. Increased toxicity 
is often the result of the production of reactive metabolites 
(Gillette, 1973). The metabolising enzymes required for the 
production of active metabolites have been shown to be present at 
some stage of gestation in both laboratory animals and man. 
Generally, the activity of these enzymes in the fetus is considerably 
lower than in the adult. However, due to the much greater 
sensitivity of fetal tissue to damage, low levels of metabolism may 
be sufficient to produce active metabolites, toxic to the fetus 
(Pelkonen, 1982).
1.3*1 Petal Toxicity
A number of studies have shown that fetal tissues have the capacity 
to produce active metabolites. Sehgal and Hutton (1977) showed that 
fetal rat liver, lung, intestine and skin converted 2-aminoanthracene
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and ‘benzo(a)pyrene to active metabolites mutagenic in the Ames Test. 
Pretreatment of the pregnant rats with 3-methylcholanthrene increased 
the mutagenicity of the compounds. Juchau et al. (1979) 
demonstrated that fetal rat liver, lung and brain and fetal mouse 
liver and lung were capable of converting 7,12-dimethyl- 
benzo(a)anthracene, benzo(a)pyrene and 2-acetaminofluorene to 
mutagenic metabolites. Human fetal tissues in vitro have been shown 
to be capable of epoxidation of benzo(a)pyrene and diphenylhydantoin, 
hydroxylation of paracetamol and N-oxidation of aniline, all 
metabolic reactions thought to be involved in the toxicity of these 
compounds (Pelkonen, 1982).
There are a number of cases where an association between the 
production of active metabolites and toxicity in the fetus has been 
suggested, Diphenylhydantoin produces resorptions and malformations 
in the fetal rat. Blake et al. (1978) found an increased incidence 
of resorptions and malformations if diphenylhydantoin was 
co-administered with trichloropropene oxide (an epoxide hydrolase 
inhibitor). They also found covalent binding of the 
diphenylhydantoin to fetal macromolecules. This suggests that an 
active metabolite capable of binding to fetal macromolecules may be 
involved in the teratogenicity. However, trichloropropene oxide is 
itself a teratogenic agent and although the investigators found a 
higher incidence of malformations when the two compounds were 
co-administered than either one produced on its own, the possibility 
of synergism cannot be discounted.
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Lambert and Webert (1977) found that mouse strains responsive to 
induction of oxidative metabolism by polycyclic hydrocarbons were 
more likely to produce stillbirths and resorptions as a result of 
treatment with 7,12-dimethylbenzo(a)anthracene and 3-methyl­
cholanthrene than were non-responsive strains of mice. Shaum et al. 
(1979) showed that benzo(a)pyrene, given at day 7 or 10 of gestation 
caused more in utero toxicity and teratogenicity in genetically 
responsive as opposed to genetically non-responsive mice. Thus, 
these results appear to indicate that metabolism is involved in the 
fetal toxicity of these compounds. However, Poland and Glover (1980) 
suggested that the fetotoxicity may be a result of the association of 
the polycyclic hydrocarbons with a cytosolic induction receptor 
protein, giving rise to a deleterious expression or repression of 
gene(s), controlled by the receptor. This problem remains unsolved.
1.3*2 Transplacental Carcinogenesis
A number of compounds, when administered to pregnant animals have 
been shown to produce tumours in the offspring (Kleihues, 1982). 
These include polycyclic aromatic hydrocarbons, nitrosamines and 
synthetic oestrogens. Fetal tissues are known from studies with 
alkylating agents to be as much as fifty fold more sensitive than 
adult tissues to direct acting carcinogens. This may be due to the 
high rate of cell division (Rice, 1981), There are many examples of 
transplacental carcinogenesis in laboratory animals. Tumours of the
nervous system have been produced in the offspring of pregnant rats
administered N-methyl-N-nitrosourea, 7,12-dimethylbenzo(a)anthracene 
or dimethyl sulphate (Napalkov, 1973; Napalkov and Alexandrov, 1974; 
Druckrey, 1973)* However, only one case of transplacental
carcinogenesis has so far been uncovered in man.
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Diethylstilboestrol, a synthetic oestrogen widely used during the 
fifties and sixties for the prevention of miscarriage, has been shown 
to cause vaginal adenocarcinoma in the female offspring of women 
taking diethylstilboestrol during pregnancy. The tumours appeared 7 
to 27 years after in utero exposure to the compound (Herbst et al., 
1971; Greenwald et al., 1971).
Metabolic activation has been shown to be important for the 
carcinogenicity of a number of xenobiotics in adult tissues. A 
number of carcinogens requiring metabolic activation in the adult are 
also carcinogenic when administered transplacentally. The importance 
of metabolic activation in transplacental carcinogenesis has been 
investigated with respect to maternal, placental and fetal 
metabolism.
Reznik-Schuller et al. (1980) administered diethylnitrosamine to 
pregnant hamsters on days 11 and 15 of pregnancy. Offspring treated 
on day 11 showed no signs of tumour formation whereas offspring 
treated on day 15 of gestation showed a 95 percent incidence of 
tracheal tumours. The extent of binding of tritiated 
diethylnitrosamine to fetal hamster trachea was also measured. On 
day 11 there was no bound radioactivity but in the fetuses that were 
treated on day 15 of gestation, radioactivity bound to the tracheal 
tissue could be detected. Thus, it seems likely that the 
transplacental carcinogenicity of the diethylnitrosamine in the 
hamster is dependent on the ability of the target fetal cells in the 
trachea to bind the nitrosamines and/or their metabolites. This may 
be a result of the fact that prior to day 12 a number of fetal 
tissues are not well differentiated giving rise to an inability to
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metabolise carcinogens to an active form, or may merely be a 
reflection of the lack of sensitivity of the tissue to carcinogenesis 
at that particular developmental stage of the fetus.
Juchau et al. (1978) studied the bioactivation of 7,12-dimethyl- 
benzo(a)anthracene and benzo(a)pyrene in a ' number of fetal human 
tissues. They found that fetal human liver, lung, kidney and adrenal 
gland were able to convert by microsomal monooxygenation
7.12-dimethylbenzo(a)anthracene and benzo(a)pyrene to metabolites 
that are positive in the Ames test. The transplacental 
carcinogenicity of 7,12-dimethylbenzo(a)anthracene in the human is 
not known, however. Rice et al. (1978) demonstrated that
7.12-dimethylbenzo(a)anthracene is a transplacental carcinogen in the 
rat.
1.4 Methods for the Assessment of Fetal Drug Metabolism 
Fetal drug metabolism may be investigated in vivo, in tissue and 
organ culture, freshly isolated or cultured cells, homogenates and 
subcellular preparations or reconstituted purified enzyme systems.
In Vivo Studies
This technique involves the administration of the xenobiotic to the 
mother and assessing the metabolites present in the fetus. The 
advantages of the system are that placental transfer and placental 
and maternal metabolism are taken into account, yielding an overall 
picture of the metabolism. However, this method does not permit an 
estimation of the fetal contribution to the total metabolism to be 
made and it cannot be used to investigate human fetal metabolism due 
to ethical considerations.
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Organ Culture
This involves the maintainance of an organ fragment at a culture 
medium- gas interface. Advantages of this system are that the cell 
arrangement within the tissue is preserved, all the cell types 
present in the tissue are cultured and the organ culture can usually 
he maintained for long periods of time. Problems arise as a result 
of necrosis of the tissue and changes in its morphology.
Isolated and Cultured Cells
Cells are usually isolated by enzymic digestion of tissues using 
enzymes such as collagenase, protease and trypsin. Cells can be used 
for drug metabolism studies as suspensions immediately after 
isolation or can be established in culture (often as a monolayer)
before use. The advantage of the freshly isolated cell suspension is
the likelyhood that the in vivo characteristics of the cells will not 
have been lost. The advantage of the cultured cells is the longer 
length of time for which the cells may be incubated with substrate. 
Cultured cells may also be used for induction studies (Fry and 
Bridges, 1977).
Cell Homogenates and Subcellular Fractions
These preparations involve disruption of tissue samples and
subsequent fractionation of cell organelles. The advantages of using 
subcellular fractions and homogenates include the ease of preparation 
and immediate availability for use. The disadvantages include the 
limited length of time for which the preparation remains viable, 
changes in the homogenate and fractions due to the release of 
hydrolytic enzymes and subsequent destruction of membranes, 
activation or inhibition of metabolising enzymes, the need to
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supplement the fractions with cofactors and the lack of assessment of 
cell uptake of the xenobiotic.
Particular problems have been found in the preparation of subcellular 
fractions of fetal liver. A study carried out by Ackermann et al. 
(1972) showed that fetal human liver responds quite differently from 
adult rat liver in homogenisation and microsome preparation. They 
found that when fetal human liver was homogenised according to
Ernster et al. (1962), the technique routinely used for the
preparation of adult rat liver microsomes, only 20 percent of the
total cytochrome P-450 was found in the microsomal (l05,000xg) 
pellet. They concluded that the cells in the fetal human liver are 
resistant to homogenisation, possibly as a result of their small size 
and resultant resistance to shear forces.
Reconstituted Purified Enzyme Systems
This technique has not yet been used for studying the fetal drug 
metabolising enzymes. This is probably due to the large amounts of 
tissue that would be required to prepare the purified enzymes. 
Purification of the fetal enzymes would provide useful information on 
the nature of the fetal enzymes, particularly in relation to the
adult enzymes.
1.5 Aims of the Study
In general, drug metabolism in the fetus has been investigated using 
homogenised tissue or subcellular fractions. Petal hepatocytes in 
culture have been used less frequently and reports of studies 
utilizing freshly isolated cells are almost non-existent. Studies in
32
cell suspension and culture have the advantage of an increased 
possible incubation time in comparison with homogenates or 
subcellular fractions, thus allowing studies of the low levels of 
metabolism seen in the fetus to be made more easily.
The aim of this study has been to investigate the use of freshly 
isolated and cultured fetal hepatocytes as a means of assessing fetal 
drug metabolism. This should enable the possible role of drug 
metabolism in fetal toxicity, at present poorly understood, to be 
investigated more easily.
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CHAPTER TWO : MATERIALS AND METHODS
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2.1 Animals
Male and female Wistar albino rats, bred at the University of Surrey 
Animal Unit were used. The animals were allowed free access to food 
and water and received standard laboratory diet (Laboratory Diet 1 , 
Spratt's Laboratory Services). Between five and eight female rats 
were mated overnight with one male. The following day was termed day 
one of pregnancy. Pregnancy was confirmed between days fourteen and 
twenty by palpation.
2.2 Materials
Ham's F 12 Medium, Liebovitz L-15 Medium, tryptose phosphate broth, 
neonatal calf serum, fetal calf serum and penicillin-streptomycin 
were purchased from Gibco Biocult (Paisley, Scotland). Tissue 
culture flasks were obtained from Nunc (Paisley, Scotland) and from 
Falcon (Becton Dickinson, Cowley, Oxfordshire). Collagenase (Type 
CLS II) was obtained from Worthington (Flow Laboratories, Uxbridge, 
Middlesex). Aryl sulphatase (type H-l), 3-glucuronidase (type H-1), 
saccharo-1,4-Â-lactone, HEPES buffer, metyrapone, 3-methyl­
cholanthrene, 3-naphthoflavone, bovine serum albumin (fraction V), 
horse heart cytochrome c, chick egg albumin, rabbit muscle lactate 
dehydrogenase, beef liver catalase, reduced nicotinamide adenine 
dinucleotide and cycloheximide were obtained from Sigma Chemical 
Company (Poole, Dorset). Ethoxycoumarin and a-naphthoflavone were 
purchased from Aldrich (Gillingham, Dorset) and 7-hydroxycoumarin 
from Fluka A.G. (Basle, Switzerland). Insulin was obtained from 
MaCarthy's Pharmaceuticals Ltd. (Painford, Essex), Actinomycin D 
was obtained from Merck, Sharp and Dohme Research Laboratories 
(Rahway New Jersey, USA). Rabbit muscle phosphorylase A and beef 
liver glutamate dehydrogenase were obtained from The Boehringer
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Corporation (Lewes,Sussex). Horse radish peroxidase-antiperoxidase 
immunoglobulin complex was obtained from Daco (Norway). Materials 
for polyacrylamide gel electrophoresis were obtained from BioRad 
(Watford, Hertfordshire). Agarose 25 was purchased from British Drug 
Houses (Poole, Dorset). Arochlor was a kind gift of Dr. S. Hubbard 
(Robens Institute of Industrial, Environmental, Health and Safety, 
Guildford, Surrey). Resorufin and analogues of ethoxyresorufin were 
a kind gift of Dr D. Burke (University of Aberdeen, Scotland). 
Swine-anti-rabbit immunoglobulin was a kind gift of Guildhay 
(Guildford, Surrey). Anti-cytochrome P-450 immunoglobulin was a kind 
gift of R. Makowski and anti-cytochrome P-448 immunoglobulin, a kind 
gift of Dr. H. Masson (University of Surrey, Guildford, Surrey).
2.3 Preparation of Petal Rat Hepatocytes
Hepatocytes were isolated using a modification of the method of Fry 
et al. (1976). The pregnant female rat was killed by cervical 
dislocation, the abdomen swabbed with 70 percent alcohol (v/v) and 
the uterus removed. Each fetus was dissected away from the placenta 
and decapitated. The liver from each fetus was placed into PBS'A' 
Dulbecco’s calcium and magnesium- free phosphate buffered saline 
(Paul, 1970). The liver was separated into lobes and each lobe was 
cut into about five small pieces with a sharp scalpel blade. Any 
pieces of connective tissue present were removed.
The pieces of liver were placed in a 250 ml conical flask with 10 ml 
PBS'A' and shaken at 37° C for 10 minutes in a shaking water bath 
(approximately 40 oscillations per minute). The buffer was removed 
and the pieces of liver washed twice, each time in 10 ml PBS'A' for 
ten minutes in the shaking water bath, to remove most of the blood.
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The liver pieces were then washed twice in PBS*A' (lOml) containing 
0.5 mM EGTA, to chelate calcium and encourage the separation of the 
cells. After the EGTA treatment the liver pieces were incubated at 
37°C in 'the shaking water bath (approximately 120 oscillations per 
minute) in 10 ml Hanlc's- magnesium free balanced salt solution 
containing CaCJ^and 0.05 percent collagenase, for 40 to 60 
minutes.
The resulting cell suspension was filtered through bolting cloth (125 
um pore size) to remove undigested liver. The filtrate was 
centrifuged at 50xg for 60 seconds and the pellet washed twice in 
PBS*A* (20ml). The cells were immediately resuspended in Ham’s E-12 
culture medium buffered with 25mM HEPES and supplemented with 10 
percent (v/v) neonatal calf serum, penicillin (20i,u./ml) and 
streptomycin (2Qpg/ml). For each 10 fetal livers, 10ml of medium was 
used to resuspend the cells. Viability was assessed on the basis of 
the ability of the cells to exclude trypan blue. Cell suspension 
(250^1) and 100 p.l 0.4 percent (w/v) trypan blue were mixed and the 
cells counted in a Neubauer Improved Counting Chamber. Percentage 
viability and total yield were calculated,
2.4 Culture of Petal Rat Hepatocytes
For the preparation of cell cultures, hepatocytes were isolated using 
aseptic techniques. All apparatus used was heat sterilized. Cells 
were diluted to one million cells/ml in culture medium. Aliquots 
(4ml) were inoculated into tissue culture flasks. The cells were 
incubated at 37° C for approximately four hours, during which time 
attachment of the cells occurred. The culture medium was removed and 
replaced with fresh medium. The medium was again replaced after a
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further fifteen hours and thereafter at 24 hour intervals.
2.5 Drug Metabolism Studies in Freshly Isolated Cells
Freshly isolated cell suspensions were diluted to five million 
cells/ml with culture medium. Cells (15 million) were incubated with 
substrate for a maximum of 3 hours at 37°C in a shaking water bath 
(80 oscillations per minute). Cells showed good viability (> 90
percent) at the end of a three hour incubation period. After 
incubation the cell suspensions were centrifuged at 200xg. The 
supernatant was removed and assayed for product. The cell pellets 
were resuspended in 0.5M NaOH (3ml), incubated at 37°C for one hour 
to dissolve the protein and the total cellular protein determined 
(see section 2.14).
2.6 Drug Metabolism Studies in Cultured Cells
Culture medium was removed from the cultures and replaced with fresh 
medium containing substrate. Cells (approximately 3 million) were 
incubated with substrate for a maximum of three hours at 37^C in an 
incubator. After incubation the medium was removed and assayed for 
product. The cell monolayers were washed with PBS'A* (approximately 
6ml), the attached cells resuspended in 0.5M ïïaOH (4ml), incubated at 
37°C for one hour and total protein determined (see section 2.14).
2.7 Determination of 7-Ethoxycoumarin 0-Deethylase Activity
A stock of 140 mM 7-ethoxycoumarin was prepared in dimethyl 
formamide. An aliquot was added to the cell suspensions and cultures 
to give a final concentration of 70pM. Suspensions and cultures were 
incubated with the 7-ethoxycoumarin for three hours at 37^C. The 
reaction was terminated by separating the medium from the cells.
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Aliquots (lml) of the medium were incubated for 15 hours at 37°C with 
0.2ml 0.2M acetate buffer, pH 4*5, containing ^-glucuronidase 
(5rag/ml) to liberate 7-hydroxycoumarin from its glucuronide 
conjugate. The impure ^-glucuronidase preparation contained 
sufficient sulphatase activity to hydrolyse the sulphate conjugate of 
the 7-hydroxycoumarin.
The hydrolysed medium was extracted with hexane (5ml) by shaking for 
10 minutes and the hexane layer discarded, as this contained 
unmetabolised 7-ethoxycouraarin. The 7-hydroxycoumarin was extracted 
into 5ml diethyl ether containing 1 .5 percent isoamyl alcohol (v/v) 
for 10 minutes. A sample of the ether phase (2ml) was back extracted 
into 0.2M glycine/ HaOH buffer, pH 10,4 (5ml) for 10 minutes. The 
extracted 7-hydroxycoumarin was measured fluorimetrically on either a 
Perkin Elmer MPP-3 or LS-5 fluorescence spectrophotometer, using an 
excitation wavelength of 370 nm and an emission wavelength of 450 nm. 
Blanks of medium from cultures incubated without 7-ethoxycoumarin and 
medium incubated with 7-ethoxycoumarin in the absence of cells were 
taken through the extraction procedure along with standards of 
7-hydroxycoumarin added to blank medium to give a final concentration 
of 500nM.
2.8 Determination of 7-Alkoxyresorufin 0-Deethylase Activity 
Stock solutions of 50pM 7-methoxy-, 7-ethoxy-, 7-n-propoxy-, 
7-n-butoxy-, 7-n-pentoxy-, 7-n-hexoxy, 7-n-heptoxy-, 7-n-octoxy-, and 
phenoxazone were prepared in dimethyl sulphoxide. These compounds 
were added to the cell suspensions and cultures to give a final 
concentration of 0.5pM, Each analogue was incubated singly with the 
hepatocytes. Suspensions and cultures were incubated with each of
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the 7-alkoxy-resorufin analogues for three hours at 37*^  C. the 
reaction was terminated by separating the medium from the cells.
/ \ oAliquots (1ml) of the medium were incubated for 15 hours at 37 C with
0.2ml 0.2M acetate buffer, pH 4.5, containing ^-glucuronidase
(5mg/ml) to hydrolyse any glucuronide conjugates. The impure
p-glucuronidase preparation contained sufficient sulphatase activity
to hydrolyse any sulphate conjugates.
The resorufin was extracted from the hydrolysed medium into ethyl 
acetate (3ml) for 30 minutes. A sample of the ethyl acetate phase 
(2ml) was back extracted into 0.2M glycine/HaOH buffer, pH 10.4 
^ml) for 30 minutes. The extracted resorufin was measured 
fluorimetrically on either a Perkin Elmer MPP-3 or LS-5 fluorescence 
spectrophotometer, using an excitation wavelength of 530nm and an 
emission wavelength of 585nm. Blanks of medium from cultures 
incubated without the 7-alkoxyresorufin analogues, and medium 
incubated with the 7-alkoxyresorufin analogues in the absence of 
cells were taken through the extraction procedure along with 
standards of resorufin added to blank medium to give final 
concentrations of 0.1juM to 1)iM.
2.9 Determination of Glucuronyl Transferase and Sulphotransferase 
Activity
7-Hydroxycoumarin was used as a substrate. A stock of 140mM 
7-hydroxycoumarin was prepared in dimethylformamide. An aliquot was 
added to the cell suspensions and cultures to give a final 
concentration of 70pM. Suspensions and cultures were incubated with 
the 7-hydroxycoumarin for two hours at 37° C. The reaction was
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terminated by separating the medium from the cells.
Aliquots (lml) of the medium were extracted twice, 10 minutes each, 
with 5ml diethyl ether containing 1-5 percent (v/v) isoamyl alcohol. 
Each time the organic layer was discarded as this removed 
unconjugated 7-hydroxycoumarin. A blank to which 7-hydroxycoumarin 
(70)M) had been added was also carried through the the extraction 
procedure to estimate the amount of 7-hydroxycoumarin not removed by 
these extractions.
The aliquots of extracted medium were then incubated overnight at 
37 C with P-glucuronidase (0.2ml of a 5mg/ml solution in 0.2M acetate 
buffer, pH 4.5). The p-glucuronidase preparation contained 
sufficient sulphatase activity to hydrolyse the sulphate conjugate of 
the 7-hydroxycoumarin. This treatment liberated total 
7-hydroxycoumarin. Aliquots of extracted medium were also incubated 
overnight at 37°C with sulphatase (0.2ml of a 62.5mg/ml solution in 
0.2M acetate buffer, pH 5.0). As the sulphatase contained some 
p-glucuronidase activity, 20mM saccharo-1,4-ü-lactone was added to 
the incubation mixture to inhibit the contaminating enzyme and permit 
the estimation of the amount of sulphate conjugate formed.
The liberated 7-hydroxycoumarin was then extracted and measured in 
the same way as in the assay for ethoxycoumarin 0-deethylase activity 
(see section 2.7).
2.10 Preparation of Microsomal Fraction
Cultured cells (approximately 80 million) were rinsed with 
PBS'A’(6ml), scraped from the surface of the culture flasks and
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suspended in 10ml 50 iriM phosphate buffer pH 7.4/1*15 percent (w/v) 
KCl (buffered KCl) (lOml). Freshly isolated cells (approximately 80 
million) were washed in PBS'A' and suspended in 5ml buffered KCl 
Liver samples were minced finely and hand-homogenised in buffered KCl 
(5ml) using a Potter-Elvehjem homogeniser. Cell suspensions and 
hand-homogenised tissue samples were kept on ice and sonicated for 
three 10 second bursts on a Dawe Soniprobe, setting 3, at 3 amps, 
with cooling in between each period of sonication. Complete 
disruption of the cells was confirmed by light microscopy. The
homogenates were centrifuged at 10,000g for 20 minutes and the
supernatant at 104,000g for one hour. Microsomal fractions were
resuspended in 50mM phosphate buffer pH 7.4 containing ImM EDTA and
20 percent (v/v) glycerol (50 - lOOul) and stored at -80°C.
2.11 Determination of Cytochrome P450
This was carried using a modification of the method of Jakobsson and
Cinti (1973). Microsomal fraction was diluted to 2mg protein per ml
in 50mM phosphate buffer pH 7*4 containing ImM EDTA and 20 percent
(v/v) glycerol. A stock solution of 1M sodium succinate in phosphate
buffer was prepared and added to each cuvette to give a final
concentration of 1OmM. A base line was recorded between 400 nm and
500 nm on a Varian Carey 219 spectrophotometer. A stock solution of
5 percent (w/v) MADE in buffer was prepared and added to the sample
cuvette to give a final concentration of 0.0625 percent w/v. A
spectrum was then recorded and an absorption peak at 427 nm,
characteristic of cytochrome b was observed. An equal amount of BADED
was then added to the reference cuvette. The contents of both 
cuvettes were mixed and bubbled for 30 seconds with CO gas. The 
sample was then divided again between the two cuvettes and a new a
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base line recorded. A few mg of dithionite were added to the sample 
cuvette and the reduced CO binding spectrum of cytochrome P450 
recorded between 400 and 500nm. The concentration of cytochrome P450 
was calculated using the difference extinction coefficient
s ”1 "1(450-490nm) of 91mM cm
2.12 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis 
This was carried out using the discontinuous technique of Laemmli 
(1970). The gel comprised a 3 percent stacking gel and a 10 percent 
running gel. The stacking gel was prepared in 1 .5M Tris buffer pH 
8.8 and the running gel in 500mM Tris buffer pH 6.8. Both buffers 
contained 0.4 percent (w/v) sodium dodecyl sulphate (SDS). The 
running gel was 80mm in length. Microsomal suspensions were diluted 
to 2mg microsomal protein per ml with 50mM phosphate buffer pH 7.4 
containing ImM EDTA and 20 percent (v/v) glycerol. The microsomal 
suspensions were then further diluted 1:1 with sample buffer (62.5mM 
Tris buffer pH 6.8, containing 2.3 percent (w/v) SDS, 15 percent 
(v/v) glycerol, 5 percent (v/v) 2-mercaptoethanol and 0.001 percent 
bromophenol blue, and heated in a boiling water bath for 3 minutes. 
Samples containing 1 5)ig of microsomal protein were applied to each 
well. The gels were run at room temperature, with a 25mM Tris, 192mM 
glycine electrode buffer pH 6.8 containing 0.1 percent (w/v) SDS. 
Migration through the stacking gel was carried out at 20mA and 
through the running gel at 40 mA. Gels were stained overnight in 
isopropanol: acetic acid: water (25:10:65) containing 0.05 percent
w/v Coomassie blue R250 and destained in isopropanol: acetic acid:
water (10:10:80). Standards used were cytochrome c (molecular weight 
12,400), lactate dehydrogenase (mwt 36,000), creatinine phosphokinase 
(mwt 40,000), chick egg albumin (43,000), glutamate dehydrogenase
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(mwt 53,000), catalane (mwt 60,000), bovine serum albumin (mwt 
68,000) and phosphorylase a (mwt 92,000); O.^pg of each protein 
standard was applied per well.
2.13 Ouchterlony Double Diffusion Analysis
This was performed essentially according to the method of Thomas et 
al (1976). Immunodiffusion gel containing 0.08M NaCl, 0.9 percent 
(w/v) immunological agarose, 0.015M sodium azide and 1M glycine was 
prepared. The pH was adjusted to 7.4 with NaOH. The gel was heated 
at 70°C until molten, poured onto glass plates (80mm x 80mm), 
precoated with a thin layer of 0.2 percent (w/v) aqueous bactoagar 
and left to solidify, Wells (4mm diameter) were punched out with a 
distance of 10mm between the centres of adjacent wells. A maximum 
volume of 20^1 of microsomal protein suspension or antiserum were 
placed in the appropriate wells. The plates were incubated at room 
temperature for 4 days, in a humid atmosphere.
After diffusion the plates were then washed 5 - 6  times over a period 
of 2 days with deproteinising solution (3 percent (w/v) HaCl, 0.01 
percent (w/v) sodium azide and 0.01 percent (v/v) Tween 20). This 
was carried out by leaving the plates to stand in the deproteinising 
solution for 4-6 hours and removing the moisture from the gel by 
absorption into tissue paper held over the gel by a weight. The 
plates were then reimmersed in the deproteinising solution and the 
process repeated 5-6 times. Finally, the plates were dried in warm 
air and stained for 7 - 10 minutes in 0.5 percent (w/v) Coomassie 
blue R250 in 96 percent (v/v) ethanol: acetic acid: water, (9:2:9)
and destained in 96 percent (v/v) ethanol: acetic acid: water,
(5:2:9).
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2.14 Estimation of Protein
Protein concentrations were determined by the method of Lowry et al, 
(1951) using bovine serum albumin as the standard.
2.15 Haematoxylin and Eosin Staining of Cultured Cells
Cells were fixed in acetic acid: 96 percent (v/v) ethanol:
formalin, (5:85:10) for five minutes and rinsed twice in tap 
water.The cells were stained with Harris's haematoxylin for three 
minutes and again rinsed twice with tap water. They were then 
differentiated with 0.5 percent (v/v) HCl for 15 seconds and the HCl 
removed and replaced with 0.5 percent (w/v) aqueous lithium carbonate 
for five minutes. The cells were rinsed with 70 percent (v/v) 
ethanol and stained with 0.5 percent (w/v) eosin in 96 percent (v/v) 
ethanol for one minute. This was followed by three rinses in 
absolute ethanol. The cultures were photographed immediately.
2.16 Peroxidase-Antiperoxidase Immunological Staining of Petal 
Hepatocytes and Sections of Various Fetal Organs
Fetal organs and cultured hepatocytes were fixed in 10 percent 
neutral buffered formalin for at least a week. Freshly isolated 
fetal hepatocytes were applied to glass slides, air dried and stored 
in 10 percent neutral buffered formalin. Fetal organs were embedded 
in wax and sections cut. The sections were dewaxed, washed in 
methanol and slowly rehydrated.
The sections were washed in running water for 10 minutes, treated 
with blocking agent(100 volume hydrogen peroxide:methanol 12:22) for 
10 minutes, washed again for 10 minutes in running water and treated 
for 30 minutes with 1 percent normal swine serum in 0.025M
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Tris/HCl-0.15M saline buffer pH 7.6 (Tris-saline). Excess serum was 
then removed by shaking and the sections were left overnight in 
contact with the first antibody (rabbit anti-rat cytochrome P-448 or 
cytochrome P-450 antiserum as described in Table 4.4; diluted 1:200 
and 1:100 respectively with 1 percent normal swine serum.
The sections were rinsed twice for 10 minutes with Tris-saline and 
exposed to the second antibody (swine anti-rabbit immunoglobulin, 
diluted 1:30) for 40 minutes. Two ten minute rinses with Tris-saline 
were followed by exposure for 40 minutes to the third antibody (a 
horse radish peroxidase conjugated to rabbit immunoglobulin) and then 
a further two 10 minute rinses with Tris-saline. The sections were 
then incubated with the chromogen diaminobenzidine (0.37mg/ml in 
citrate buffer) for 3 minutes, washed for ten minutes in running 
water, counterstained with Harris's haematoxylin, dehydrated and 
mounted. Appropriate controls for non-specific staining were also 
performed.
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CHAPTER THREE ; DRUG METABOLISM STUDIES IN FRESH AND CULTURED 
FETAL RAT HEPATOCYTES
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3.1 Histological Assessment of Fresh and Cultured Fetal Hepatocytes
3 .1.1 Results
Figure 3.1 is a photograph of freshly isolated fetal hepatocytes
stained with trypan blue. Viability of the cells is greater than 99
percent, and remains greater than 90 percent during a three hour 
incubation of a cell suspension. Figure 3.2 shows haematoxylin and 
eosin stained fetal hepatocytes after three hours in culture. The 
cells are firmly attached to the plastic surface of the culture 
vessel and have begun to lose their rounded appearance. Small
colonies of cells are visible. Haematoxylin and eosin stained fetal 
hepatocytes cultured for 24 hours are shown in figure 3.3. After 24 
hours in culture, the cells have flattened out considerably and areas 
of growth of large flattened cells similar to those of liver derived 
cell lines begin to appear. Figure 3.4 shows haematoxylin and eosin 
stained 48 hour old cultures of fetal hepatocytes. These cultures 
are similar in appearance to the 24 hour old cultures but the large 
flattened cells are more evident. Throughout the 48 hour culture
period, mitotic figures, indicating active cell division, may be 
observed in the hepatocytes.
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Figure 3.1
Stained with Trypan Blue Freshly Isolated Fetal Hepatocytes(Mag. X788)
Figure 3.2 Hepatocytes Cultured for 3 hoursStained with Haematoxylin-Eosin (Mag. X200)
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Figure 3*5 Hepatocytes Cultured for 24 hoursStained with Haematoxylin-Eosin (Mag. X200)
Figure 3*4 Hepatocytes Cultured for 48 hoursStained with Haematoxylin-Eosin (Mag. X200)
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3.2 7-Ethoxycoumarin 0-Deethylase Activity in Fresh and Cultured 
Petal Hepatocytes on Days 16-22 of Gestation
3.2.1 Introduction
7-Ethoxycoumarin is deethylated to 7-hydroxycoumarin by the 
cytochrome P-450 metabolising system (Ullrich and Weber, 1972).
H 5C2O' HO
7-ETHOXYCOUMARIH 7-HYDROXYCOUMARIN
7-Hydroxycoumarin is highly fluorescent and enables low levels of 
metabolism to be measured. Thus, the 0-deethylation of 
7-ethoxycoumarin is an appropriate assay to use in the investigation 
of phase I metabolism in fetal hepatocytes, where the drug 
metabolising activity is low.
Ullrich and Weber (1972) investigated the enzyme kinetics of the 
7-ethoxycoumarin 0-deethylase reaction. They found evidence for two 
enzymes with differing Km values. Phenobarbitone induction of the 
animals affected the dealkylation activity of the lower affinity 
enzyme while the dealkylation activity of the higher affinity enzyme 
was much more sensitive to inhibition by hexanol. Metyrapone 
competitively inhibited the dealkylation of the lower affinity enzyme 
and the sensitivity to inhibition seemed to be higher than for the 
reaction with high affinity.
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3.2.2 Results
Hepatocytes were isolated from fetuses on day 16 to 22 of gestation. 
Two to four litters were pooled, depending on fetal age. The cells 
were either used as fresh suspensions (0-3 hours) or they were 
cultured. 7-Bthoxycoumarin 0-deethylase activity was measured in the 
freshly prepared hepatocytes and in the hepatocytes cultured for 6, 
9, 12, 24 and 48 hours. Cell suspensions only were prepared from 16
day old fetuses because of limited availability of material. The 
7-ethoxycoumarin 0-deethylase activity in cells prepared from 19 and 
20 day old fetuses was measured on two occasions with similar results 
being obtained.
Figures 3.5 - 3.10 show the 7-ethoxycoumarin 0-deethylase activity 
measured in the freshly isolated and cultured fetal hepatocytes, 
prepared from fetuses on days 17 to 22 of gestation, at various times 
after isolation. This information is summarized in table 3.1. No 
7-ethoxycoumarin 0-deethylase activity was detectable in the fetal 
hepatocyte suspensions prepared from 16 day old fetuses.
The results show that the 7-ethoxycoumarin 0-deethylase activity 
changes markedly in the fetal hepatocytes as the length of time in 
culture increases. In all cases a large increase in 7-ethoxycoumarin 
0-deethylase activity is seen during the first 24 hours in culture. 
An increase in activity is also seen between 24 and 48 hours for 
fetal hepatocytes prepared from fetuses aged 1 9 - 2 2  days, but the 
ethoxycoumarin 0-deethylase activity in the cultured cells from the 
17 and 18 day old fetuses decreased over this period. Over the first 
24 hours in culture, the fold increase in activity seen, is greatest 
for the hepatocytes isolated from 17 day old fetuses. The fold
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increase in activity seen on culturing decreased with increasing 
fetal age (see figure 3.11)•
Figure 3.12 shows the 7-ethoxycoumarin 0-deethylase activity in 
freshly isolated fetal cells on days 17 - 22 of gestation. There is 
an increase in activity of approximately 20-fold between days 17 and 
22.
A
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FIGURE 3.5 7-ETHOXYCOUMARIN 0-DEETHYLASE ACTIVITY IN FRESH AND CULTURED
HEPATOCYTES FROM FETUSES OF 1? DAYS GESTATIONAL AGE.
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FIGURE 3.6 7-ETHOXYCOUMARIN 0-DEETHYLASE ACTIVITY IN FRESH AND CULTURED
HEPATOCYTES FROM FETUSES OF 18 DAYS GESTATIONAL AGE.
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FIGURE 3.7 7-ETHOXYCOUMARIN 0-üEETHYLASE ACTIVITY IN FRESH AND CULTURED
HEPATOCYTES FROM FETUSES OF I9 DAYS GESTATIONAL AGE.
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FIGURE 3.8 7-ETHüXYGOUMARIN 0-DEETHYLASE ACTIVITY IN FRESH AND CULTURED
HEiATOCYTES FROM FETUSES OF 21 DAYS GESTATIONAL AGE.
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FIGUHE 3.9 7-ETHOXYCOUMARIN 0-DEETHYLASE ACTIVITY IN FRESH AND CULTURED
HEPATOCYTES FROM FETUSES OF 21 DAYS GESTATIONAL AGE.
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FIGURE 3.10 7-ETHOXYCOUMARIN 0-DEETHYLASE ACTIVITY IN FRESH AND CULTURED
HEPATOCYTES FROM FETUSES OF 22 DAYS GESTATIONAL AGE.
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FIGURE 3.11 7-ETHOXYCOUMARIN 0-DEETHYLASE ACTIVITY IN FRESH AND CULTURED
HEPATOCYTES ON DAYS 1? - 22 OF GESTATION.
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FIGURE 3.12 7-ETHOXYGOUMARIN 0-DEETHYLASE ACTIVITY IN FllESHLY ISOLATED
FETAL HEIATOCYTES ON DAYS 17-22 OF GESTATION
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TABLE 3.1 7-ETHOXYCOUMARIN 0-DEETHYLASE ACTIVITY IN FRESH AND
CULTURED HEPATOCYTES FROM 17-22 DAY OLD FETAL RATS
INCUBATION 
PERIOD (h)
AGE OF FETUS (days)
17 18 19 20 21 22
pmols of 7-îiydroxycoumarin produced/mg protein/3h
0-3 8.4 22.8 79.2 46.2 60.0 118.5
60.39 60.96 68.7 6 2.1 613.8 612.6
3-6 931.8 617.1 507.9 453-9 343.5 302.1
±44.7 6120.9 622.5 6 46 .8 ±20.7 ±14.1
6-9 1536.0 960.3 1065.9 825.3 751.8 544-8
±69 .3 ±8 5 .5 654 .3 ±144-0 ±54-9 622.9
9- 12 1043-1 1153.5 1390.2 801.0 1279.2 512.4
±101.4 ±6 4 .8 ±63 .3 ±75 .9 ±69 .6 6 I9 .8
21-24 1720.8 1208.1 1551.6 1284.2 1357-2 495-6
±69-9 ±120.0 ±101.7 ±34-5 ±145.5 ±62.4
45-48 425 .4 117.3 2557.5 1582.8 3120 .9 2951.7
±47.1 ±17.1 ±71.4 ±59 .7 ±218.7 ±180.9
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3.3 Studies on the Inhibition of 7-Ethoxycoumarin 0-Deethylase
3.3.1 Introduction
Different forms of cytochrome P-450 show different inhibition 
characteristics. The cytochrome P-450 inhibitors metyrapone and 
a-naphthoflavone are commonly used to distinguish between the P-450 
and P-448 types of cytochrome.
Metyrapone is a pyridine derivative.
METYRAPONE
Metyrapone is a good inhibitor of some cytochrome P-450 catalysed 
reactions but not of others. For example, metyrapone has been shown 
to be a good inhibitor for p-nitroanisole N-demethylation but a poor 
inhibitor of aniline hydroxylation (Testa and Jenner, 1981). Leibman 
(1969) observed that metyrapone inhibits the metabolism of
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hexobarbital and aminopyrine. Metyrapone, however, enhances the 
oxidative metabolism of acetanilide at concentrations below lOmM and 
only inhibits the hydroxylation of acetanilide above this 
concentration. Metyrapone is a stronger ligand for
phenobarbitone-induced forms of cytochrome P-450 than polycyclic 
aromatic hydrocarbon-induced forms (Ullrich and Kremers, 1977). 
Metyrapone also inhibits the cytochrome P-450 induced by trans 
stilbene oxide (Pucker et al., 1979).
a-Uaphthoflavone has the structure:
O
The nature of the inhibition of cytochrome P-450-mediated reactions 
by a-naphthoflavone is complex and appears to vary with species, 
strain, sex and organ. This is probably a result of the differing 
effect of a-naphthoflavone on different cytochrome P-450 isoenzymes 
(Testa and Jenner, 1981). The inhibition of cytochrome P-450 
produced by a-naphthoflavone is considered to be due to substrate
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competition for the active site of the enzyme (Lesca et al., 1979). 
It appears that a-naphthoflavone is only metabolised by certain 
cytochrome P-450 isoenzymes (Vyas et al., 1983). This may account 
for the variation in extent of inhibition by a-naphthoflavone of the 
different forms.
Ullrich and Kremers (1977), investigating multiple forms of 
cytochrome P-450 found that a-naphthoflavone was a good inhibitor for 
the P-448 type of cytochrome but not for the P-450 type of 
cytochrome. Johnson et al. (1979) investigated the inhibition of 
two purified rabbit liver microsomal cytochromes P-450 prepared from 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rabbits. The 
cytochrome P-450 considered to belong to the
"phenobarbitone-inducible group of cytochromes" was only poorly 
inhibited by a-naphthoflavone while the cytochrome P-450 considered 
to belong to the "benzo(a)pyrene-inducible group of cytochromes" was 
strongly inhibited by the a-naphthoflavone.
In vitro, the addition of a-naphthoflavone can stimulate ’ cytochrome 
P-450 activity under certain conditions (Cinti, 1978). Only the 
reactions catalysed by native and phenobarbitone-induced forms of 
cytochrome P-450 appear to be stimulated.
Wiebel and Gelboin (1975) found that a-naphthoflavone enhanced aryl 
hydrocarbon hydroxylase activity in pre-term fetuses while at twenty 
days post-delivery the aryl hydrocarbon hydroxylase activity was 
inhibited by a-naphthoflavone. This suggests that the nature of the 
inhibition of cytochrome(s) P-450 changes during post natal
development.
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3.5.2 Results
The effect of the inhibitors a-naphthoflavone and metyrapone on 
7-ethoxycoumarin 0-deethylase activity in fresh fetal hepatocytes and 
those cultured for 6, 24 and 48 hours was investigated. Hepatocytes 
were isolated from 20 day old rat fetuses, from 3 pooled litters. 
The cells were incubated with 7-ethoxycoumarin (70^M) and with 
metyrapone (lml) or a-naphthoflavone (lOOpM) or no inhibitor for 3 
hours.
Table 3.2 shows the results of this study. The 7-ethoxycoumarin 
0-deethylase activity, in the presence and absence of the two 
inhibitors, is shown with standard errors for four replicate cell 
preparations. The 7-ethoxycoumarin 0-deethylase activity in the
inhibitor-treated cells is also shown as a percentage of the activity 
in the untreated cells. This information is summarized in figure 
3.13 which is a histogram of the 7-ethoxycoumarin 0-deethylase 
activity in the inhibitor-treated cells, shown as a percentage of the 
7-ethoxycoumarin 0-deethylase activity in the untreated cells.
With increasing time in culture, there is a steady increase in the
percentage inhibition seen with a-naphthoflavone, from an inhibition 
of approximately 25 percent to 95 percent. Metyrapone gave an 
inhibition of approximately 55 percent at both the 0-3 and 3-6 hour
time points. At the 21-24 hour time point, the metyrapone gave an
inhibition of approximately 95 percent and at 45-48 hours, an 
inhibition of 85 percent.
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The inhibition of 7-ethoxycoumarin 0-deethylase activity by 
metyrapone and a-naphthoflavone in freshly isolated hepatocytes from 
fetuses of different gestational ages was investigated, in order to 
ascertain whether the degree of inhibition was dependent on fetal 
age. Hepatocytes were prepared from fetuses of gestational ages 
18-22 days and from day old neonates. Two or three litters were 
pooled in each case. The hepatocytes were incubated, as freshly 
isolated suspensions, with 7-ethoxycoumarin (70yuM) and with 
metyrapone (imM) or a-naphthoflavone (lOOpM) or no inhibitor for 3 
hours.
The results are shown in table 3.3. The 7-ethoxycoumarin 
0-deethylase activity, in the presence and absence of the two
inhibitors, is shown with standard errors for five replicate cell
preparations. The 7-ethoxycoumarin 0-deethylase activity in the 
inhibitor-treated cells is also shown as a percentage of the activity 
in the untreated cells.
There appears to be no trend in the inhibition of 7-ethoxycoumarin 
0-deethylase activity either by a-naphthoflavone or by metyrapone 
with respect to fetal age. However, greater inhibition by metyrapone 
is generally reflected by less inhibition by a-naphthoflavone. At 19 
and 22 days of gestation and in the one-day old neonate, an
activation of 7-ethoxycoumarin 0-deethylase activity by
a-naphthoflavone was seen. This activation was greatest in the 
hepatocytes from fetuses of 22 days of gestational age and
constituted a 2.4-fold increase in 0-deethylase activity.
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FIGURE 3.13 INHIBITION OF 7-ETHOXYCOUMARIN 0-DEETHYLASE ACTIVITY IN 
FRESH AND CULTURED HEPATOCYTES FROM FETUSES OF 20 DAYS 
GESTATIONAL AGE.
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TABLE 3.2 THE EFFECT OF METYRAPONE AND a-NAPHTHOFLAVONE ON 7-ETHOXYCOUMARIN 
0-DEETHYLASE ACTIVITY IN FRESH AND CULTURED HEPATOCYTES FROM FETUSES OF 20 
DAYS GESTATIONAL AGE.
TIME IN INHIBITOR ECOD* SEM fo OF UNINHIBITEDCULTURE (h) ACTIVITY REACTION
0-3 none 60.0 + 8.7met 21.1 + 3.0 43.9ANF 43.9 ± 3.^ 76.4
3-6 none 246.9 4- 18.3met 103.0 + 10.8 42.3ANF 81.3 ± 12.3 32.9
21-24 none 1330.0 + 47.7 _met 71.4 + 8.7 5.3ANF 211.3 ± 33.3 13.7
45-48 none 2373.1 +136.8met 336.4 ± 71.7 13.0ANF 126.6 + 20.1 3.3
SEM - standard error of the mean 
ECOD - 7-ethoxycoumarin 0-deethylase
met - metyrapone 
ANF - a-naphthoflavone
pmols of 7-hydroxycoumarin produced/mg of protein/3 hours
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5*4 7-Ethoxyresorufin 0~Deethylase Activity in Fresh and Cultured 
Fetal Hepatocytes on Day 20 of Gestation
3.4.1 Introduction
7-Ethoxyresorufin (7-ethoxyphenoxazone) is deethylated by the 
cytochrome P-450 system to the highly fluorescent resorufin 
(7-hydroxyphenoxazone) (Burke and Mayer, 1974).
O C 2H 5 OH
7-ETHOXYRESORUFIN RESORUFIN
The dééthylation of 7-ethoxyresorufin is inducible by 3-methyl- 
cholanthrene but not by phenobarbitone. 3-Methyl-
cholanthrene-pretreatment induces 7-ethoxyresorufin 0-deethylase 
activity 200-fold in adult male rat. This suggests that 
7-ethoxyresorufin is metabolised by the P-448 type of cytochrome 
(Burke et al., 1977). Further evidence supporting this has been 
provided by Nilsen et al. (1981) who investigated 7-ethoxyresorufin 
0-deethylase activity in reconstituted systems of purified rabbit 
liver microsomal cytochromes P-450. Metabolism of 7-ethoxyresorufin 
was not detectable when cytochrome P-450LM2, the form inducible by 
phenobarbitone, was reconstituted. However, 7-ethoxyresorufin was a 
good substrate for the reconstituted cytochrome P-450LM4, the form 
inducible by 3-methylcholanthrene. Gibson et al. (l982) 
investigated 7-ethoxyresorufin 0-deethylase activity in reconstituted
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systems of purified rat liver microsomal cytochromes P-450 from 
animals induced with p-naphthoflavone or phenobarbitone. They found 
that 7-ethoxresorufin was a good substrate for the cytochrome 
purified from the p-naphthoflavone-treated rats which had a reduced 
CO-binding difference maximum at 447nm, whereas only a trace of 
activity was detectable with the reconstituted cytochrome P-450 
prepared from phenobartltone-pretreated rats, which had a reduced 
CO-binding maximum at 450nm.
5.4.2 Results
Hepatocytes were isolated from 20 day old rat fetuses, from the 
pooled litters of 5 pregnant females. The cells were either used 
fresh as suspensions (0-5 hours) or they were cultured. 
7-Bthoxyresorufin 0-deethylase activity was measured in the freshly 
prepared hepatocytes and in the hepatocytes cultured for 6, 9, 24 and 
48 hours.
Figure 3.14 shows the 7-ethoxyresorufin 0-deethylase activity 
measured in the freshly isolated and cultured fetal hepatocytes. At 
0-3 hours a very small amount of activity was present. As the length 
of time in culture increased a marked increase in 7-ethoxyresorufin 
0-deethylase occurred.
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FIGURE 3.14 7-ETHOXYRESORUFIN 0-DEETHYLASE ACTIVITY IN FRESH AND CULTURED
HEPATOCYTES FROM FETUSES OF 20 DAYS GESTATIONAL AGE.
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3.5 Metabolism of Some Alkyl Analogues of Ethoxyresorufin in 
Hepatocytes Prom Fetuses of 20 Days Gestational Age
3.5.1 Introduction
Burke and Mayer (1983) investigated the effect of chain length on the 
metabolism of alkyl analogues of ethoxyresorufin in control mice and 
in mice pretreated with either phenobarbitone or 3-methyl­
cholanthrene. They found that the pattern of metabolism of the alkyl 
ether phenoxazone analogues was dependent on the pretreatment of the 
mice. Phenoxazone, methoxyresorufin and ethoxyresorufin were the 
best substrates for the control microsomal enzymes, whereas
phenobarbitone-induced microsomal enzymes showed a preference for
phenoxazone and the n-pentyl ether. 3-Methylcholanthrene -induced 
microsomes were highly selective for ethoxyresorufin and to a lesser 
degree methoxy-, n-propoxy- and n-butoxyresorufin while phenoxazone 
and other ether homologues were very poor substrates.
3.5.2 Results
Hepatocytes were isolated from 20 day old rat fetuses from the pooled 
litters of three females. The cells were either used fresh or were 
cultured for 48 hours. The dealkylation of the analogues of
resorufin from - Cg, and the hydroxylation of phenoxazone to yield 
resorufin were measured in freshly isolated cells between 0 and 3 
hours and in cultured cells between 45 and 48 hours after cell 
isolation.
Metabolism was barely detectable in the freshly isolated cells for 
all the alkoxyresorufin analogues and for phenoxazone. There was 
little difference between any of the analogues in the amount of 
resorufin produced. Detectable dealkylase activity was seen for
?3
certain analogues in the cells cultured for 4 8  hours. These results
are shown in table 3 « 4 .
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TABLE 3.4 METABOLISM OF 7-ALKOXYRESORUFIN ANALOGUES AND
PHENOXAZONE IN HEPATOCYTES FROM FETUSES OF 20 DAYS GESTATIONAL
AGE, CULTURED FOR 48 HOURS
SUBSTRATE ACTIVITY* SEM
methoxyresorufin 33.7 ± 4.7
ethoxyresorufin 667.3 ± 33.2
propoxyresorufin 905.0 ±111.0
hutoxyresorufin 330.0 ± 34.3
pentoxyresorufin N.D.
hexoxyresorufin N.D.
heptoxyresorufin N.D.
Gctoxyresorufin N.D.
phenoxazone N.D.
* - (pmols of resorufin produced/mg protein/3h) 
N.D. - not detectable
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3«6 Glucuronic Acid and Sulphuric Acid Conjugation of 7-Hydroxy- 
CGumarin in Fresh and Cultured Fetal Hepatocytes on Day 20 
of Gestation
3.6.1 Introduction
Glucuronic acid and sulphuric acid conjugation are both phase II 
conjugation reactions. Sulphotransferase, a cytosolic enzyme, 
requires 3'-phosphoadenosine 5’phosphosulphate (PAPS) as a 
cosuhstrate while glucuronyl transferase, a microsomal enzyme, 
requires UDP-glucuronic acid (UDP-GA) as cosuhstrate.
Moldeus et al. (1979) found that isolated adult rat hepatocytes
contain low levels of PAPS and UDP-GA. Constant synthesis of these 
factors is necessary for maximal rates of sulphate conjugation and 
glucuronidation. Sulphate conjugation was found to he dependent on 
an adequate supply of extracellular sulphate. This may he supplied
as inorganic sulphate or as cysteine or methionine.
Sulphotransferase is considered to have a high affinity for its 
substrates but a low capacity while glucuronyl transferase is 
considered to have a high capacity for metabolism but less affinity 
for its substrates than sulphotransferase (Andersson et al. 1978).
3.6.2 Results
Hepatocytes were isolated from 20 day old rat fetuses, from the 
pooled litters of three pregnant females. The cells were either used 
fresh as suspensions (0-2 hours) or they were cultured.
7-Hydroxycoumarin glucuronyl transferase and sulphotransferase 
activities were measured in the fresh cells and in the cultured cells 
at 2-4, 22-24, and 46-48 hours.
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Figures 3*15 and 3*16 show the 7-hydroxycoumarin 
glucuronyltransferase and sulphotransferase activity respectively. 
Glucuronyl transferase activity increased three-fold to a maximum 
after 24 hours in culture. Sulphotransferase activity represented 
approximately 10 percent of the activity of glucuronyl transferase. 
The activity increased slowly in culture and was 50 percent higher 
after 48 hours in culture.
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FIGURE 3.15 7-HYDHOXYCOUMARIN GLUCURONYL TRANSFERASE ACTIVITY IN FRESH
AND CULTUREU HEPATOCYTES FROM FETUSES OF 20 DAYS GESTATIONAL 
AGE.
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IGURE 3.16 7-HYDROXYCOUMARIN SULPHOTRANSFERASE ACTIVITY IN FRESH AND
CULTURED HEPATOCYTES FROM ['ICTUSES OF 20 DAYS GESTATIONAL AGE,
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3*7 Measurement of Cytochrome P-450 in Fresh and Cultured Hepatocytes 
from Fetuses of 20 Days Gestational Age 
3*7.1 Introduction
The concentration of total microsomal cytochrome P-450 may he 
measured from the absorbance peak around 450nm, of the reduced 
cytochrome P-450-C0 complex in a difference spectrum using 
dithionite-reduced microsomal fraction as the reference. The 
wavelength of the peak absorbance varies, usually between 447 and 
452nm depending on the composition of the microsomal fraction with 
respect to various isoenzymes of cytochrome P-450. Guenther and 
Hebert (1978) measured the total cytochrome P-450 concentration in 
microsomes prepared from fetal rat liver and found that the 
concentration was 26pmol/rag microsomal protein at day 18, 65pmol /mg 
microsomal protein at day 20 and 200pmol /mg microsomal protein at 
day 22, In each case the peak for the reduced haemoprotein 
CO-complex was at 450nm. Kremers et al. (1981) measured cytochrome 
P-450 concentrations in cultured hepatocytes prepared from 18-20 day 
old rat fetuses and found it to be 40pmol/mg microsomal protein after 
24 hours in culture. The peak for the reduced haemoprotein 
CO-complex was at 450nm.
3.7.2 Results
Hepatocytes were isolated from 20 day old rat fetuses, from 5 pooled 
litters. Approximately half the cells were used immediately to 
prepare microsomal fractions. The remainder were culture for 48 
hours, the cells harvested and microsomal fractions prepared.
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The cytochrome P-450 concentration in the microsomal fraction 
prepared from the freshly isolated cells was 43.3pmol/mg microsomal 
protein and that of the microsomal fraction prepared from the 
cultured cells 95.1pmol/mg microsomal protein. The microsomal 
fractions prepared from both the freshly isolated and cultured fetal 
hepatocytes gave reduced haemoprotein CO-complex maxima at 450nm.
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3.8 The Effect of Actinomycin D and Cycloheximide on 7-Ethoxycoumarin
0-Deethylase Activity in Cultured Fetal Hepatocytes from Fetuses 
of 20 days Gestational Age.
3.8.1 Introduction
Actinomycin D is an antibiotic produced by Streptomyces species. It 
blocks transcription of DHA to mRNA by blocking the template function 
of DNA, preventing mRNA chain elongation. It can inhibit 
transcription without affecting other aspects of cell metabolism. 
Cycloheximide inhibits protein synthesis by 80S ribosomes. It blocks 
the formation of peptide bonds (Lehninger, 1975).
Hebert and Gielen (1971) utilized actinomycin D and cycloheximide to 
investigate induction processes in cultured fetal hepatocytes. A 
concentration of 0.4^M actinomycin D was found to inhibit 95 percent 
of the gross cellular RHA synthesis. Cycloheximide, at a 
concentration of 3. 5juM, was found to inhibit 85 percent of the total 
cellular protein synthesis. Cells could be incubated with 
cycloheximide for 12 hours and actinomycin D for 8 hours before any 
signs of irreversible cytotoxicity was observed.
3.8.2 Results
Cells were isolated from 20 day old rat fetuses and cultured for 6 
hours in the presence or absence of actinomycin D (0.4pM) and in the 
presence or absence of cycloheximide (3.5jiM). The hepatocytes were 
also incubated between 3 and 6 hours with 7-ethoxycoumarin. The 
effects of the cycloheximide and actinomycin D are shown in table 
3.5.
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TABLE 3.5 EFFECT OF ACTINOMYCIN D AND CYCLOHEXIMIDE ON
7-ETHOXYCOUMARIN 0-DEETHYLASE ACTIVITY IN FETAL HEPATOCYTES
CULTURED FOR SIX HOURS
ADDITION TO 7-ECOD'*"
CULTURE ACTIVITY
none 294.0
SEM
± 1 0 . 8
7-ECOD ACTIVITY (AS % OF 
OF UNTREATED CULTURE)
actinomycin D 200.2 ±22.3 68.0
cycloheximide 106.0 ± 7.3 36.1
* - 7-ethoxycoumarin O-deethylase (nmols 7-hydroxycoumarin 
produced/mg protein/3 hours)
7-Ethoxycoumarin O-deethylase activity, in the presence of 
cycloheximide, was 36 percent that of untreated cells while in the 
presence of actinomycin D the 7-ethoxycoumarin O-deethylase activity 
was 68 percent that of the untreated cells. In comparison to 
previously determined values for 7-ethoxycoumarin O-deethylase 
activity in freshly isolated hepatocytes there was an approximate
6-fold increase in 7-ethoxycoumarin O-deethylase activity in the 
untreated cells after 6 hours in culture, an approximately 5-fold 
increase in the actinomycin D-treated cells and only a 2-fold 
increase in the cycloheximide-treated cells.
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3.9 Polyacrylamide Gel Electrophoresis of Microsomal Fractions From 
Freshly Isolated and Cultured Fetal and Adult Rat Hepatocytes
3 .9.1 Introduction
Sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis is a 
technique for the separation of small amounts of protein on the basis
of their molecular weight. Changes in the proportions of multiple
forms of microsomal cytochromes P-450 present in a particular organ 
can be monitored using 8D8 polyacrylamide gel electrophoresis.
Microsomal fractions are prepared, separated by 8D8 ^ lyacrylamide gel 
electrophoresis and changes in the proteins in the molecular weight 
range 45,000-60,000 are investigated.
8harma et al. (l979) found that 3-methylcholanthrene and
P-naphthoflavone caused an increase in microsomal proteins of 
molecular weight 54,000 and 56,000. Guenther and Nebert (1978) used 
SDS polyacrylamide gel electrophoresis to investigate the effects of 
tetrachlorodibenzo-p-dioxin on fetal microsomal proteins. They found 
increased amounts of three proteins having molecular weights of
51,000, 54,000 and 56,000. Fahl et al. (1979) used SDS
polyacrylamide gel electrophoresis to investigate the effect of 
3-methylcholanthrene and phenobarbitone on cultured adult 
hepatocytes. They found that 3-methylcholanthrene produced an
increase in a protein of molecular weight 56,000 while the
hepatocytes were unaffected by the phenobarbitone.
3.9.2 Results
Hepatocytes were prepared from 20 day old rat fetuses, from 5 pooled 
litters. Approximately half of the cells were used immediately to 
prepare a microsomal fraction. The remainder were cultured for 48
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hours, the hepatocytes harvested and a microsomal fraction prepared. 
Hepatocytes were prepared from adult rat liver by the perfusion 
method of Rao et al. (1976). Approximately half of the cells were 
used immediately to prepared a microsomal fraction. The remainder 
were cultured for 3 days in Liebovitz L-15 medium supplemented with 
fetal calf serum (10 percent), tryptose phosphate broth (lO percent) 
and penecillin/streptomycin (lOOiu and 1OC^g/ml respectively). The 
same conditions were used for culture of the adult cells as for the 
fetal cells. The adult hepatocytes were harvested and a microsomal 
fraction prepared.
Figure 3.17 is a photograph of a sodium dodecyl sulphate (SDS) 
polyacrylamide gel separation of the microsomal fractions. Wells
1-10 contained:
1 . Standard protein mixture
2. Purified cytochrome P-448
3. Microsomal fraction from cultured adult hepatocytes *
4. Microsomal fraction from fresh adult hepatocytes
5. Purified Cytochrome P-450
6. Standard protein mixture
7. Microsomal fraction from fresh fetal hepatocytes
8. Microsomal fraction from cultured fetal hepatocytes
9. Standard protein mixture
10. Purified cytochrome P-450 reductase
The microsomal fractions from the fresh and cultured fetal 
hepatocytes showed no observable differences in the qualitative and 
quantitative pattern of the separated proteins. Differences were
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apparent, however, between the microsomal fractions from the fresh 
and cultured adult hepatocytes. A protein of molecular weight 
48,000-50,000 was present in the adult microsomal fraction from the 
fresh hepatocytes but absent from the adult microsomal fraction from 
the cultured hepatocytes. In addition, a protein of molecular weight 
54p00-56,000 was present in the cultured adult cells in much greater 
quantities than in the fresh hepatocytes. The two proteins are shown 
in figure 3-17 as a and b respectively.
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Protein b Protein a
Figure 3.17 Sodium Dodecyl Sulphate Polyacrylamide Gel Separation of Microsomal Fractions from Fresh and Cultured Fetal and Adult Rat Hepatocytes.
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3.10 Immunocytochemical Staining of Freshly Isolated and Cultured 
Fetal Hepatocytes with Anti-Cytochrome P-450 and 
Anti-Cytochrome P-448
3.10.1 Introduction
Immunocytochemistry is the identification of a tissue constituent in 
situ hy means of a specific antigen-antibody reaction tagged by a
visible label. The visible label may be produced in a number of
ways. One way is to use a peroxidase anti-peroxidase label. The 
peroxidase-antiperoxidase method of immunocytochemical staining 
utilises a three-antibody technique. The primary antibody is raised 
to the specific antigen to be identified. The second antibody is
raised against the first in a different species. The third is an
immunoglobulin raised in the first species against horse radish 
peroxidase and then allowed to complex with it. This is illustrated 
below:
PEROXIDASE-ANTIPEROXIDASE COMPLEX
RABBIT IMMUNOGLOBULIN
PEROXIDASE
SWINE ANTI-RABBIT
RABBIT ANTI-RAT CYTOCHROME P-450 
RAT CYTOCHROME P-450
The peroxidase then catalyses the oxidation of diaminobenzidine to 
form a product which rapidly polymerises to an insoluble brown 
deposit.
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3»10,2 Results
Hépatocytes were isolated from 20 day old rat fetuses from 2 pooled 
litters. The cells were either used as freshly isolated suspensions 
or were cultured for either 3 or 48 hours. Freshly isolated cells 
were applied to a glass slide as a smear and air dried. They were 
then fixed in neutral buffered formalin. Cultured hepatocytes were 
washed in PBS’A’ and also fixed in formalin. The fresh and cultured 
hepatocytes were then stained with anti-cytochrome P-450 and 
anti-cytochrome P-448 (See table 4.4). Figures 3.18 to 3.23 are 
photographs of freshly isolated and cultured cells stained with 
either anti-cytochrome P-450 or anti-cytochrome P-448. The freshly 
isolated cells showed very little staining with either antibody. 
After 3 and 48 hours in culture, staining is apparent with both 
antibodies.
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Figure 3.18 Freshly Isolated Fetal Hepatocytes
Stained with Anti-P-450 (Mag. X500)
Figure 3.19 Freshly Isolated Fetal Hepatocytes
Stained with Anti-P-448 (Mag. X500)
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#
Figure 3.20 Fetal Hepatocytes Cultured for 3 hoursStained with Anti-P-450 (Mag. X500)
a A
A
Figure 3.21 Fetal Hepatocytes Cultured for 3 hours
Stained with Anti P-448 (Mag. X500)
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r
Figure 3.22 Fetal Hepatocytes Cultured for 48 hoursStained with Anti-P-450 (Mag. X500)
92
4
Figure 3*23a Fetal Hepatocytes Cultured for 48 hoursStained with Anti-P-448 (Mag, X313)
Figure 3.23b Fetal Hepatocytes Cultured for 48 hoursStained with Anti-P-448 (Mag. X^OO)
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3.11 The Effect of Insulin on Cultured Fetal Hepatocytes
3 .11.1 Introduction
Generally, mixed function oxidase activity is much lower in the fetus 
than in the adult. Redmond and Hichola (1981) in an attempt to 
explain this, hypothesised that there existed an inverse relationship 
between the rate of cell growth and mixed function oxidase activity. 
They proposed that resources within the cell are always limited and 
therefore the cell can either actively divide and grow or can carry 
out xenobiotic oxidations. Thus, rapidly dividing cells may not be 
able to carry out rapid drug metabolism. This hypothesis also 
suggests that growth promoting hormones inhibit drug metabolism and 
hormones which promote differentiation stimulate drug metabolising 
activity. Current evidence suggests that insulin plays a growth 
promoting role in the fetus.
In the fetal rat, insulin levels are high in comparison to adult 
values. These levels are maintained until birth, when a large drop 
in insulin level is seen (Cohen and Turner, 1972). Since a rise in 
mixed function oxidase activity is seen in the early neonatal rat, it 
is possible that insulin may have an influence on mixed function 
oxidase activity in the fetal rat.
Past and Cook (1982) investigated monooxygenase activity in 
alloxan-induced diabetic rats. They found that solubilized hepatic 
microsomal fractions from the diabetic rats exhibited a 52,000 
molecular weight haemoprotein band that was not present in the sodium 
dodecyl sulphate - polyacrylamide gel electrophoresis protein 
profiles of identically solubilized hepatic microsomal fractions from 
normal, 3-methylcholanthrene- or phenobarbitone-treated rats. The
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haemoprotein disappeared on insulin treatment. Thus, in the adult 
rat, insulin appears to have a specific effect on the relative 
amounts of the hepatic cytochromes P-450 present.
3 .11.2 Results
Fetal hepatocytes were prepared from 20 day old fetuses and cultured 
for 48 hours in the absence of insulin or in the presence of a range 
of concentrations of insulin. The insulin, used as supplied by the 
manufacturers, was added directly into the medium to give final 
concentrations of 0.001, 0.01, 0.1, 1.0, 10.0 and 100.0mIU/ml. Every 
12 hours the medium was removed from the cells and replaced with 
fresh insulin-containing medium. At 45 hours after isolation, the 
medium was removed and replaced with fresh medium containing insulin 
and 7-ethoxycoumarin. The cultures were then incubated for three 
hours and the 7-ethoxycoumarin 0-deethylase activity measured.
Figure 3.24 shows the 7-ethoxycoumarin 0-deethylase activity in the 
presence of the different concentrations of insulin. It can be seen 
that insulin, at concentrations of 0.001, 0.01 and 0.1mIU/ml had no 
statistically significant effect on the 7-ethoxycoumarin 0-deethylase 
activity of the cultured fetal hepatocytes. At concentrations of 1 .0 
and 10.0 mlU/ml a statistically significant depression of the 
monooxygenase activity was seen, whilst at a concentration of 
100mIU/ml a statistically significant increase in 7-ethoxycoumarin 
0-deethylase activity was seen.
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FIGURE 3.24 THE EFFECT OF ADDING INSULIN TO THE CULTURE MEDIUM ON THE 
7-ETHOXYCOUMARIN 0-DEETHYLASE ACTIVITY IN HEiATOCYTES FROM 
FETUSES OF 20 DAYS GESTATIONAL AGE, CULTURED FOR 48 HOURS
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3.12 Discussion
3.12.1 Histological Assessment of Fresh and Cultured Fetal 
Hepatocytes
The freshly isolated cells showed a viability in excess of 99 
percent. After a three hour incubation there was little loss of 
viability. The freshly isolated fetal hepatocytes are a mixture of 
different cell types, including parenchymal cells, haematopoietic 
cells and white blood cells. It is difficult to estimate the 
percentage of the different cell types attaching in culture as 
identification of individual cell types is difficult, the cells are 
continually replicating and many are binucleate, making the 
estimation of cell numbers difficult. It is generally considered 
that red blood cells are unable to attach in culture.
Experiments have been carried out using both suspensions of freshly 
isolated cells and cells attached in culture. These two preparations 
differ in that the cells in suspension acquire a rounded appearance 
as a result of the isolation procedure while the cells in monolayer 
culture become spread out with an appearance similar to that seen in 
vivo. This change in shape must necessitate an alteration in the 
cell membrane. The effect of this on the accessibility of nutrients, 
oxygen and substrate to the cell is unknown.
3.12.2 The Effect of Culture on Phase I and Phase II Metabolism
On culture, fetal rat hepatocytes show a large increase in 
7-ethoxycoumarin 0-deethylase activity and in 7-ethoxyresorufin 
0-deethylase activity. However, UDP-glucuronyl transferase and 
sulphotransferase only show a very small increase in activity on 
culture. Thus, it is probable, though not impossible, that the
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increase in 7-ethexycoumarin 0-deethylase and 7-ethoxyresorufin 
0-deethylase activity is a phenomenon related to phase I metabolism 
only.
There are a number of possible explanations for the rise in 
7-ethoxycoumarin 0-deethylase and 7-ethoxyresorufin 0-deethylase 
activity seen . It is possible that there is a change in the
population of the cells present in the cultures, increasing the 
percentage of drug metabolising cells present. However, it seems 
unlikely that an increase of the magnitude seen could be explained on 
the basis of such a change in the cell population since such an 
increase would almost certainly lead to a large change in total 
protein in the cultures. Such a change in total protein is not seen. 
Additionally, a change in cell population would not explain the
altered inhibition characteristics of the enzyme seen on culturing. 
A change in cell population, however, is the most likely explanation 
for the increase in UDP-glucuronyl transferase and sulphotransferase
activity, since the majority of the increase in enzyme activity is
seen between 0-2 and 2-4 hours, the time between using freshly 
isolated hepatocyte suspensions and using the cells in culture. The 
activity of the UDP-glucuronyl transferase and sulphotransferase is 
little changed between 24 and 48 hours.
An increased availability of substrate or cofactors is another 
possible explanation for the observed increase in 7-ethoxycoumarin 
0-deethylase activity. This would not, however, explain the apparent 
change in the nature of the enzyme, as demonstrated by the inhibitor 
studies.
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Either an activation of the enzyme or the removal of an inhibiting 
factor could be responsible for the increase in the 7-ethoxycoumarin 
0-deethylase activity seen. This increase could also be explained as 
a result of a stimulation of de novo synthesis of the enzyme, a 
removal of an inhibition of de novo synthesis of the enzyme, a 
decrease in the rate of degradation of the enzyme or a combination of 
these factors.
For the first two of these explanations, no change in the amount of 
enzyme present would be seen. However, for the third and fourth 
explanations, an increase in the total amount of enzyme present would 
be expected. The increase in total amount of enzyme would not 
necessarily, however, have to parallel the increase in activity if 
the new enzyme synthesised had a different specific activity.
An attempt was made to measure the total cytochrome P-450 present in 
the fresh and cultured cells, to discover whether there were changes 
in total cellular cytochrome P-450 occurring during the culture 
period. However, the fetal liver is involved in the production .of 
large amounts of haemoglobin making the preparation of 
haemoglobin-free microsomal fractions from fetal liver difficult. 
When the method of Omura and Sato (1964) is used to measure the P-450 
content of the microsomal fraction prepared from the fetal 
hepatocytes, the CO-haemoglobin peak obscures the P-450 spectrum. 
This problem was overcome by using a modification of the method of 
Ohno et al. (1982). Succinate was added to both cuvettes to reduce 
mitochondrial cytochromes; NADH was added to both cuvettes to 
equalize the cytochrome b^; both cuvettes were gassed with CO to 
equalize haemoglobin and dithionite was added to the sample cuvette
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and the cytochrome P-450 spectrum recorded.
The cytochrome P-450 concentration in the microsomal fraction 
prepared from the freshly isolated cells was 43.3pmol/mg microsomal 
protein and from the cultured cells, 95»1pmol/mg microsomal protein.
This measurement was only performed once and therefore cannot be 
considered conclusive. However, it is in good agreement with the 
values Of fetal rat P-450 concentration as determined by Kremers et 
al. (1981). The values determined for the cytochrome P-450 
concentration in the fresh and cultured fetal hepatocytes suggest 
that there may be an increase of approximately two fold in the total 
cellular cytochrome P-450 occurring in the cultured cells. This 
would indicate the appearance of a cytochrome with an increased 
specific activity with respect to the dééthylation of 
7-ethoxycoumarin and 7-ethôxyresôrufin. This new cytochrome may 
correspond to a form isolated by Imai (1979) from 3-methyl- 
cholanthrene-treated rats. This form, which he called P-448g had a 
very high 7-ethoxycoumarin 0-deethylase activity in comparison to two 
forms of cytochrome P-450 called P-450^ and P-450^, which were 
isolated from phenobarbitone-treated rats.
De novo synthesis of a protein usually involves the transcription of 
D M  to mRNA and the translation Of the m R M  to the protein. Protein 
and R M  synthesis inhibition studies were undertaken to investigate 
whether either, both Or neither of these processes were requirements 
for the increase in 7-ethoxycOumarin 0-deethylase and
7-ethoxyresorufin 0-deethylase activity seen On culture. Prom table
3.5 it can be seen that cycloheximide reduced 7-ethôxycôumarin
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0-deethylase activity by 64 percent. Thus, it would appear that
protein synthesis is very likely to be a prerequisite for the culture 
-induced increase in the activity Of 7-ethoxycoumarin 0-deethylase.
Actinomycin D, an RNA synthesis inhibitor, reduced the enzyme 
activity by only 32 percent. This is less than would be expected on 
the basis of the results of the investigation of Nebert and Gielen 
(1971) in cultured fetal hepatocytes. They were able to inhibit
induction of benzo(a)pyrene hydroxylation by benz©(a)anthracene with 
an actinomycin D concentration of 40nM. This difference could be due 
to the synthesis Of the mRNA taking place during the period Of cell 
isolation reducing the sensitivity of the cells to the actinomycin D 
in the post-isolation period as compared to the concomitant 
incubation of the cells with the actinomycin D and benzo(a)anthracene 
in the Nebert investigation. It is also possible that the mRNA for 
the cytochrome appearing in the cultures was already present in the 
cells before cell isolation took place and culture of the cells 
activated the translation of the mRNA.
The rate Of dealkylation of a number of analogues Of alkyl ethers Of 
phenoxazone is shown in table 3«4. Burke and Mayer (1983) suggested 
that the nature of the metabolism of this series is determined by the 
nature of the cytochrome responsible for their metabolism. The 
pattern of metabolism of the analogues in cultured fetal hepatocytes 
most closely resembles that seen in adult mice induced with 3-methyl- 
cholanthrene. Levels of metabolism were too low in the freshly 
isolated cells for any conclusions to be drawn about the nature of 
the cytochrome present in these cells. Burke and Mayer (1983) found 
that ethoxyresorufin was the best substrate for the 3-methyl-
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chôlanthrene-induced form of the enzyme, whereas In the cultured 
fetal hepatocytes in the present study, propoxyresorufin showed the 
fastest rate of dealkylation. This may he due to variation between 
the rat and the mouse or may be due to sOme difference in the nature 
Of the cytochrome.
Sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis was 
used to investigate changes in the microsomal polypeptide profile of 
fresh and cultured fetal hepatocytes, particularly in the molecular 
weight region 45,000 to 60,000. This is the region in which the
cytochromes P-450 are found. The microsomal polypeptide profiles of 
fresh and cultured adult rat hepatocytes were also examined for 
comparison with the fetal hepatocytes.
Prom figure 3»17 it can be seen that there are no observable
differences in the microsomal polypeptide profiles Of the fresh and 
cultured fetal hepatocytes. However, differences are apparent 
between the microsomal polypeptide profiles Of the fresh and cultured 
adult hepatocytes. A protein of molecular weight 48,000-50,000 (a in 
figure 3.17) is present in the fresh cells but absent from the
cultured cells. This protein may correspond to the form of 
cytochrome P-450 which is considered to be lost from adult
hepatocytes during culture (Guzelian et al., 1977). This protein was 
not the same as the cytochrome P-450 purified from 
phenobarbitone-treated rats and had a slightly lower molecular 
weight. A protein of molecular weight 54,000-56,000 (b in figure 
3.17) appears to be present in increased amounts in the cultured 
hepatocytes as compared with the freshly isolated cells. This 
protein may correspond to the form of cytochrome which is considered
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tô become the dominant form in cultured adult hepatocytes (Pahl et 
al,, 1979). The absence of any observable change in the polypeptide 
profiles of the microsomal fractions from the fresh and cultured 
fetal hepatocytes could be due to a lack of sensitivity Of the
technique to detect changes in the low levels of cytochrome P-450
present in the fetal cells in comparison with the levels of
cytochrome P-450 present in the adult cells
Antibodies raised to certain isoenzymes of cytochrome P-450 were used 
to investigate immunecytochemically the nature Of the cytochrome(s) 
P-450 present in fresh and cultured fetal hepatocytes. Little
staining was apparent with either antibody in the freshly isolated 
fetal hepatocytes This is in conflict with the results Of the study 
using intact fetal liver tissue, where staining with the anti-P-450 
is apparent (See section 4.2). This difference may be due to 
differences in the methodology used for the staining of the two 
preparations (whole cell attached to glass slide as compared to wax 
embedded section) or may be due to the relatively small number of 
cells studied in the isolated cell preparation compared with the 
intact liver. At 3 hours and at 48 hours, staining was apparent with 
both the anti-P-450 and anti-P-448. In each case there are cells 
present which take up the stain and cells which do not. This would 
suggest specificity of the antibody. However, a full investigation 
Of the specificity Of the antibody for cytOchrOme P-450 and 
cytochrome P-448 has been carried out for tissue sections Only and 
not for studies Of whole cells. Thus, while indicating the presence 
Of cytochrome P-450 and cytochrome P-448 in the 3 and 48 hour Old 
cultures, these results . cannot be considered to yield any definite 
conclusions.
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3.12.3 The Effect of Petal Age On 7-EthOxycOumarin 0-Deethylase 
Activity in Presh and Cultured Petal Hepatocytes
Pigure 3.11 shows the 7-ethôxycôumarin 0-deethylase activity in
freshly isolated fetal hepatocytes prepared from fetuses On days 17 - 
22 Of gestation. There is a steady rise in the activity Of the 
enzyme with increasing fetal age. Activity On day 19 was higher than 
On day 20. This elevated activity may Or may not be significant and 
could be due to experimental error, interindividual variation, fetal 
enzyme induction as a result of transplacental exposure to foreign 
compounds or may be due to alterations in fetal hepatic mOnOOxygenase 
activity in late gestation. Petal tissues may be especially 
susceptible to enzyme induction by foreign compounds (see Chapter 4). 
Similar variations in the level of drug metabolising activity between 
days 17 and 22 Of gestation have been seen by Inoue et al. (1981) 
for aminOpyrine N-demethylatiOn and benzo(a)pyrene hydroxylation.
Pigure 3.12 shows the 7-ethôxycôumarin 0-deethylase activity in
freshly isolated fetal hepatocytes and in the cultured fetal
hepatocytes prepared from the fetuses On days 17-22 of gestation. In 
contrast to the steady rise in 7-ethôxycôumarin 0-deethylase activity
seen with increasing fetal age in the freshy isolated cells; at 3-6
hours and 21-24 hours there is a decrease in 7-ethOxycôumarin 
0-deethylase activity with increasing fetal age. This is reflected 
in the fact that the increase in 7-ethOxycOumarin 0-deethylase
activity seen On culture for 24 hours is greatest, both in terras of 
the fold increase in activity and in absolute amount Of 
7-ethôxycôumarin metabolised, at day 17 and decreases with increased 
fetal age.
1 0 4
On days 17 and 18 there is a decrease in 7-ethoxycoumarin 
0-deethylase activity between 24 and 48 hours. This is not observed 
at the other fetal ages. On day 22 however, a large increase in 
7-ethôxycôumarin 0-deethylase activity is observed between 24 and 48 
hours in culture. The significance of these results is not clear.
Between 6 and 12 hours either a reduced rate of increase of 
7-ethôxycôumarin 0-deethylase activity (days 18, 20 and 22) or an
actual fall in 7-ethoxycoumarin 0-deethylase activity (days 17,19 and 
21) is observed. This may signify a change in the proportions 
present in the cells Of two or more different types of cytochrome 
P-450. This hypothesis is illustrated in figure 3»25.
FIGURE 3.25
H
O
5
TIME IN CULTURE
— - total cytochrome P-430
...... increasing formof cytochrome P-430
— — decreasing formof cytochrome P-4_$0
A fall in concentration of one particular form of cytochrome P-450 is 
not an unreasonable possible explanation for this phenomenon as this 
effect is seen in cultures of adult rat hepatocytes (Guzelian et al., 
1977). In the adult rat hepatocyte cultures a fall in the P-450 type 
of cytochrome is observed. This could possibly also Occur in the 
fetal hepatocytes.
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3.12.4 Inhibition of 7-EthOxycoumarin 0-Deethylase Activity 
Pigure 3.13 shews the effect Of culture On the inhibition of 
7-ethOxycOumarin 0-deethylase activity by a-naphthoflavOne and 
metyrapOne. With increasing time in culture there is a steady 
increase in the percentage inhibition seen with a-naphthôflavône, 
from approximately 25 percent to 95 percent. This suggests a 
culture-dependent change in the nature Of the cytOchrOme P-450 
responsible for the metabolism of 7-ethoxycOumarin. Huang et al. 
(1981) investigated the inhibition Of benzo(a)pyrene hydroxylation by 
a-naphthoflavone using purified cytochrome P-450 isoenzymes from 
rabbit liver. They found a small inhibition when using the LM-4 
form. A 10-fold stimulation Of the benzo(a)pyrene hydroxylation 
Occurred with the form LM-3c as a metabolising system and a very 
strong inhibition was observed with the LM-6 form. This form was 
purified from tetrachlôrodibenzô-p-diôxin-treated rabbits. Thus, 
culture Of fetal rat hepatocytes may alter the proportions Of the 
isoenzymes of cytochrome P-450 present in the hepatocytes.
An increase in inhibition of 7-ethOxycOumarin 0-deethylase activity 
in the cultured fetal hepatocytes is also seen with metyrapOne. This 
is in contrast to the work of Bridges and Pry (l978) who saw a 
decrease in inhibition Of 7-ethôxycôumarin 0-deethylase activity by 
metyrapOne in cultures Of adult hepatocytes. This increased 
inhibition may be due tO the appearance in the cultures Of a type Of 
cytochrome inhibitable by metyrapOne.
There appears to be no trend in the inhibition of 7-ethoxycôumarin 
0-deethylase by a-naphthOflavOne and metyrapOne in freshly isolated 
fetal hepatocytes with respect to fetal age. At day 19 and 22, an
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activation Of the 7-ethôxycôumarin 0-deethylase activity by 
a-naphthoflavOne is Observed in the freshly isolated fetal 
hepatocytes. Activation of certain phase I metabolising activities 
by a-naphthoflavone has been Observed by a number Of investigators. 
The activation of benzo(a)pyrene hydroxylation was observed in fetal 
rabbit by Oraiecinski et al. (1980). Benford and Bridges (l983) 
observed the activation of biphenyl 2-hydrOxylatiOn by rat livers 
microsomal fractions. Currently, the mechanism of activation Of 
certain phase I reactions has not been elucidated. However, it does 
seem that the forms Of cytOchrOme P-450 which are susceptible to 
activation are the control and phenobarbitone inducible forms. 
(BenfOrd and Bridges, 1983).
3.12.5 The Effect Of Insulin On 7-EthOxycOumarin O-Deethylase 
Activity
From figure 3.18 it can be seen that insulin at concentrations Of
0.001, 0.01 and 0.1mIU/ml has no effect On 7-ethOxycOumarin
O-deethylase activity in fetal hepatocytes culture fOr 48 hours. 
However, at concentrations Of 1mIU/ml and10mIU/ml a statistically 
significant depression of the 7-ethoxycOumarin O-deethylase activity 
is seen. This may be related to the effect postulated by RedmOnd and 
Nicola (I98I) - see section 3.11.1. However, the maximum depression
achieved by incubation with insulin is insufficient to suggest that 
the absence Of insulin from the fetal hepatocyte cultures is 
responsible for the large increase in 7-ethoxycOumarin O-deethylase 
activity seen during culture. This cOuld be a result Of the need for 
the insulin concentration to be finely controlled over a narrow 
concentration range. This could be investigated by studying the 
effect Of a concentration range Of 1-10mIU/ml Of insulin.
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The rate of degradation Of insulin hy fetal hepatocytes is unknown. 
Blackard et al. (1978) found that in cultured adult rat hepatocytes 
the insulin concentration fell to less than 30 percent Of its initial 
level during the first 2 hours Of incubation with the cells. The 
rate Of degradation Of the insulin fell appreciably in the following 
period. A rapid rate Of degradation Of the insulin by the fetal 
hepatocytes would lead to a wide variation in the concentration Of 
insulin to which the cells would be exposed Over the culture period.
At an insulin concentration Of 10OitilU/ml a statistically significant 
increase in 7-ethoxycOumarin O-deethylase is seen. This could be due 
to down regulation Of the fetal hepatocyte insulin receptors. Down 
regulation is the reduction in number Of insulin receptors seen when 
they are exposed to high insulin concentrations. Blackard et al. 
(1978), investigating the down regulation Of insulin receptors in 
cultured adult rat hepatocytes found down regulation Occurred at 
concentrations of insulin as lOw as 4nM Over a 1 6 hour incubation 
period.
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CHAPTER POUR : INDUCTION STUDIES
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4.1 Introduction to Induction Studies
Enzyme activity may be increased as a result Of an increased rate Of 
de nOvo synthesis Of the enzyme protein, a decreased rate Of
degradation, a change in the activity of the existing enzyme molecule 
Or a combinations Of these factors. Enzyme induction is classically 
regarded as being an increase in the total amount of the enzyme 
protein.
Information On fetal induction of drug metabolism is very important 
as an increase in drug metabolising activity may potentiate the 
fetOtOxicity Of some compounds. Much controversy exists On the 
inducibility Of fetal drug metabolism. This is partly due to
problems in detecting low levels of metabolism in the fetus and
partly tO the fact that induction in the fetus is dependent upon 
species, Organ, inducer, reaction, fetal age and whether the
induction is observed in vivo Or in vitro (Klinger et al, 1978).
Nebert and Gelboin (1969) measured aryl hydrocarbon hydroxylase in 
fetal hamster hepatic micrOsOmes after induction in vivo with 
3-methylchOlanthrene Or phenobarbitone. 3-MethylchOlanthrene gave a 
10-20 fold induction and phenobarbitone a 4 fold induction, 
3-Methylcholanthrene produced a similar response in the fetal rat.
Schlede and Merker (1972) studied the induction of aryl hydrocarbon 
hydroxylase by benzo(a)pyrene on days 13-18 of gestation. They were 
unable to detect metabolism in the untreated fetuses and hence were 
unable to estimate fold induction. Induction was seen at day 13» 
increasing to day 15 and then remaining at a plateau between day 15 
and 18.
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Inôue et al, (1981) found that polychlorinated biphenyl-treatment of 
pregnant rats 72 hours before microsome preparation, the fetal 
hexobarbital and aminOpyrine Oxidative enzymes were induced about
2-fold on days 17-20 of gestation, but the benzo(a)pyrene hydroxylase 
activity was induced 37-, 56-, 115- and 25-fOld On days 17, 18, 19
and 20 respectively. The maternal liver also showed a 2-fold 
induction Of hexobarbital and aminOpyrine activity respectively, but 
Only a 10-fOld increase in benzo(a)pyrene hydrOxylatiOn. Thus, 
hexobarbital and aminOpyrine metabolism show a similar level Of 
induction in both fetal and maternal liver whereas benzo(a)pyrene 
hydroxylation appears tO be much more inducible in the fetus. These 
results suggest that there is mOre than One monOOxygenase in the 
fetal liver and that the benzo(a)pyrene hydrOxylating enzyme is 
particularly susceptible to induction.
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4.2 Results of Induction Studies
Pregnant rats were treated with inducers as indicated in table 4.1. 
Petal hepatocytes were prepared On day 20 Of gestation and used as 
fresh suspensions. Table 4.2 shows the 7-ethôxycôumarin O-deethylase 
activity in the cells isolated from the fetuses Of control and 
treated dams. A marked induction Of 7-ethôxycôumarin O-deethylase 
was produced by g-naphthoflavone, 3-methylchOlanthrene and Arôchlôr. 
p-NaphthOflavOne produced the greatest fold induction Of the 
7-ethôxycôumarin O-deethylase while 3-methylcholanthrene produced a 
66 fold and Arôchlôr a 858 fold induction. A marginal effect was 
Observed with phenobarbitone.
The effect of the inhibitors metyrapOne and a-naphthOflavOne On the 
ethOxycOumarin O-deethylase activity in the fetal hepatocytes from 
the control and treated animals was also investigated. The results 
of this study are shown in table 4.3. a-NaphthOflavOne produced a 
small inhibition Of the 7-ethOxycOumarin O-deethylase in control 
fetal hepatocytes. In the fetal hepatocytes from phenobarbitone - 
pretreated dams, an activation of the 7-ethOxycOumarin activity was 
seen. In the fetal hepatocytes from the P-naphthoflavone, ArochlOr 
and 3-methylcholanthrene pretreated dams, greater than 90 percent 
inhibition Of the 7-ethôxycôumarin O-deethylase activity by 
OC-naphthoflavOne was seen. MetyrapOne showed a 60-70 percent 
inhibition Of the 7-ethOxycOumarin O-deethylase activity in the 
control fetal hepatocytes and hepatocytes from phenobarbitone- and 
p-naphthoflavOne- pretreated animals. The fetal hepatocytes from the 
3-methylcholanthrene and ArOchlOr treated rats, however, showed a 91 
percent and 84 percent inhibition respectively with metyrapOne.
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Microsomal fractions were prepared from the fetal livers Of the 
control and treated animals. Ouchterlony immunodiffusion was 
performed On these micrOsOmal fractions using antibodies raised to a 
purified phenobarbitone- induced cytochrome P-450 (P-450 antibody), a 
purified p-naphthOflavOne- induced cytochrome P-450 (P-448 antibody) 
and a purified clofibrate- induced cytochrome P-450 (P-452 antibody). 
Figure 4.1 is a photograph Of the immunodiffusion plate. The Outer 
wells contained the antisera as shown in the figure. The centre well 
contained 600^g of fetal hepatic microsomal fraction from the 
variously induced animals as indicated in figure 4.1• Table 4.4 
lists a number Of properties of the various purified cytochromes used 
to raise the antisera. Table 4*5 indicates the degree Of 
immunoprécipitation observed between the various antibodies and the 
fetal hepatic micrôsômal fractions.
Table 4.5 indicates that the fetal hepatic microsOmal fraction from 
the control animals gave a small immunoprécipitation with the P-448 
antibody while those from ArochlOr- and 3-methylchOlanthrene-treated 
animals gave more immunoprécipitation and fetal hepatic micrôsômal 
fractions from p-naphthoflavone-treated animals gave the most 
immunoprécipitation. A small immunoprécipitation was also seen 
between the P-450 antibody and the fetal hepatic microsomal fraction 
from the ArOchlOr-treated animals and between the P-452 antibody and 
the fetal hepatic micrôsômal fraction from the 3-methyl- 
cholanthrene-treated animals.
Microsomal fractions from the fetal livers of the control and treated 
animals were also subjected to SDS polyacrylamide gel 
electrophoresis. Figure 4.2 is a photograph Of the SDS
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polyacrylamide gel. Wells 1-10 contained:
1 standard protein mixture
2 microsomal fraction frOm BWF-treated fetal liver
3 no sample
4 micrOsOmal fraction from ArOchlOr-treated fetal liver
5 micrOsOmal fraction from 3-MC-treated fetal liver
6 micrOsOmal fraction from untreated fetal liver
7 purified cytochrome P-450
8 standard protein mixture
9 purified cytochrome P-448
10 purified cytOchrOme P-450 reductase
There is no evidence from the polyacrylamide gel Of any qualitative 
Or quantitative difference between the polypeptide profiles Of the 
microsomal fractions from the control, P-naphthOflavOne-treated, 
Arôchlôr-treated Or 3-methylchOlanthrene treated animals.
Figures 4.3 - 4.12 are photographs Of sections Of liver and kidney 
taken from the fetuses Of the control and treated animals. 
Abbreviations used in the figures:
3“MC - 3-methylchOlanthrene
BNP - 3-naphthôflavône
anti-P-450 - antibody raised to purified cytOchrOme P-450 
(See table 4.4) 
anti-P-448 - antibody raised to purified cytOchrOme P-448 
(See table 4.4)
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Figures 4.3 to 4*6 are sections Of fetal liver from untreated,
3-methylcholanthrene-treated, Arochlor-treated and |3-naphthôflavône 
treated animals stained with the antibody to cytochrome P-450. 
Material immunOprecipitable by the anti-P-450 is present in all 
sections. There appears to be a little more in the fetal liver from 
the p-naphthoflavone-treated animal than in the untreated control and 
a little less in the fetal liver from the 3-methyl-
cholanthrene-treated animal.
Figures 4.7 tO 4*10 are sections of fetal liver from untreated,
3-methylchOlanthrene-treated, Arôchlôr-treated and
P-naphthOflavone-treated animals stained with the cytochrome p-448 
antibody. There is essentially nO material immunOprecipitable by the 
anti-P-448 present in the fetal livers from the untreated animal. A 
small amount was visible in some areas but the staining was so weak 
as to be irreproducible photographically. Very weak staining was 
Observed in the fetal liver section from the 3-methylchOlanthrene 
treated animal. More staining was visible in the fetal liver section 
from the Arôchlôr-treated animal. Most staining was observed in the 
fetal liver section from the ^-naphthoflavone treated animal. This 
section showed the occurrence Of vacuOlatiOn. In all the sections, 
staining with both the anti-P-450 and the anti-P-448 was confined to 
the hepatic parenchymal tissue. Areas Of haematopoietic tissue were 
devoid Of staining.
Figures 4.11 and 4.12 show fetal kidney from untreated animals 
stained with anti P-450 and anti-P-448 respectively.Staining with 
anti-P-448 was faintly visible in the fetal tubules, in the more
differentiated cells. The fetal kidney tubules showed gOOd staining
1 1 5
with the anti-P-450.
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TABLE 4.1 PRETREATMENT OP PREGNANT RATS WITH MICROSOMAL ENZYME 
INDUCERS
INDUCER VEHICLE DOSE (mg/kg) ROUTE
BNP corn Oil 80 i.p,
3-MC corn Oil 25 i.p,
AROCHLOR corn Oil 100 I.p.
CONTROL corn Oil I.p.
PB saline 60 I.p,
CONTROL saline I.p.
Pregnant rats were dOsed On days 17, 18 and 19 Of gestation. Each 
chemical was administered in 1 ml/kg Of vehicle.
BNP = P-naphthoflavOne 
5-MC = 3-methyl cholanthrene 
PB = phenObarhitOne
i.p. = intra peritoneal
TABLE 4.2 7-ETHOXYCOUMARIN 0-DEETHYLASE ACTIVITY IN PETAL
HEPATOCYTES PROM CONTROL AND TREATED ANIMALS •
17
TREATMENT 7-ECOD ACTIVITY POLD INCREASE
+(nm©ls/mg pr©tein/31i) OVER CONTROL
CONTROL (corn ©il) 0.0294 ± 0.0012
CONTROL (saline) 0.0192 I 0.0018
PB 0.0228 ± 0.0009 1 . 2
BNP 42.96 ± 1.77 1460
3-MC 1 .953 .t 0.057 66.2
AROCHLOR 25.29 ± 2.58 858
7-ECOD = 7-eth©xyc0umarin 0-deethylase
BNP = p-naphtheflavone
3-MC = 3-methyl cholanthrene
+ = nmol 7"hydroxycoumarin produced
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TABLE 4.3 THE EFFECT OF INHIBITORS ON 7-ETHOXYCOUMARIN 0-DEETHYLASE 
ACTIVITY IN FETAL HEPATOCYTES FROM CONTROL ANIMALS AND 
ANIMALS PRETREATED WITH INDUCING AGENTS
TREATMENT 7-ECOD ACTIVITY INHIBITION OF 7-ECOD ACTIVITY
(nmôl/mg prôtein/3h) (percentage ôf uninhibited reaction)
ANF METYRAPONE
CORN OIL 0.0294 85 35
SALINE 0.0192 72 27
PB 0.0228 131 58
3-MC 1.955 7.8
BNP 42.96 2.1 59
AROCHLOR 25.29 1.4 16
7-ECOD = 7-Ethôxycôumarin 0-deethylase 
(nmol 7-hydrôxycôumarin prOduced/mg prOtein/3h) 
ANF = a-naphthoflavone 
BNP = p-naphthoflavône
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TABLE 4.4 CHARACTERISTICS OE THE CYTOCHROMES USED TO RAISE
THE ANTIBODIES
CYTOCHROME M¥t CO PEAK SELECTIVE SUBSTRATE
P-448 56,000 447 Ethoxyresorufin
P-450 53,000 450 Benzphetamine
P-432 51,000 452 Laurie Acid
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TABLE 4.5 IMMUNOPRECIPITATION OF FETAL LIVER MICROSOMAL 
PREPARATIONS FROM CONTROL AND TREATED ANIMALS
DEGREE OF IMMUNOPRECIPITATION 
TREATMENT OF DAMS anti-P-450 anti-P-448 anti-P-452
(p b ) (b n f) (c lofibrate)
C o n t r o l  ( c o r n  O i l )  +
BNF — +++ —
A r O c h l O r  + + +
3-MC _ ++ +
PB - phenobarbitone 
BNF - p-naphthoflavOne
3-MC - 3-methylcholanthrene
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Figure 4.1 Ouchterlony Immunodiffusion of Fetal Liver Microsomal 
Preparations from Control and Treated Animals
BNF - p-naphthoflavone 
3-MG - 3-methylcholanthrene
1 - 1^1 of antiserum
2 - of antiserum
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Figure 4.2 Sodium Dodecyl Sulphate Polyacrylamide Gel Separation of Fetal Rat Liver Microsomal Fractions from Untreated, Arochlor-treated, 3-Methylcholanthrene-treated and P-Naphthoflavone-treated Animals.
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Figure 4.3Stained with Anti-P-450 Section of Control Fetal Liver(Mag. X500)
Figure 4.4
Stained with Anti-P-450
Section of 3-MC-Treated Fetal Liver
(Mag. X500)
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Figure 4.5 Section of Arochlor-Treated Fetal LiverStained with Anti-P-450 (Mag. X500)
Figure 4.6
Stained with Anti-P-450
Section of BNF-Treated Fetal Liver
(Mag. X500)
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Figure 4.7
Stained with Anti-P-448 Section of Control Fetal Liver(Mag. X500)
Figure 4.8 Section of 3-MC-Treated Fetal Liver
Stained with Anti-P-448 (Mag. X500)
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Figure 4.9 Section of Arochlor-Treated Fetal LiverStained with Anti-P-448 (Mag. X500)
Figure 4.10
Stained with Anti-P-448
Section of BNF-Treated Fetal Liver
(Mag. X500)
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Figure 4.11Stained with Anti-P-450 Section of Control Fetal Kidney(Mag. X79)
Figure 4.12
Stained with Anti-P-448
Section of Control Fetal Kidnei a y (Mag. X79)
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4.3 Discussion
0-Naphthôflavône and 3-methylcholanthrene are considered to be
inducers Of the P-448 type of cytOchrOme, while ArOchlOr is 
considered to induce both the P-448 and P-450 types of cytochrome. A 
marked induction of 7-ethûxycôumarin 0-deethylase activity in fetal 
hepatOcytes from p-naphthoflavône-, 3-methylchOlanthrene- and 
ArOchlOr-treated rats was Observed. Phenobarbitone, an inducer of 
the P-450 type Of cytOchrOme produced only a marginal effect on the 
7-ethOxycOumarin 0-deethylase activity. The effect Of in vivo 
induction On cytochrome P-450-mediated metabolism in freshly isolated 
fetal hepatOcytes has not previously been reported. Studies in fetal 
hepatic micrôsOmes have generally indicated that P-448 type inducers 
induce P-450 metabolism in the fetus, while phenobarbitone is
ineffective as an inducer in the fetus (Guenther and Mannering 1977).
A possible explanation for the differences in the extent Of induction 
by the different inducers may be differences in the amount Of inducer 
reaching the fetal liver. The inducers were not administered to the 
rats On an equivalent mg/kg Or mmol/kg basis. The amount 
administered varied from approximately 0.1mmOl/kg tO approximately '
0.3mmOl/kg. This constitutes an approximate 3-fôld variation in the |
dOse and is unlikely to account for the differences seen in the I
extent of induction. The amount of inducer reaching the fetal liver !
I
w i l l  a l s o  d e p e n d  o n  t h e  r a t e  O f  p l a c e n t a l  t r a n s f e r  a n d  o n
d i s t r i b u t i o n  w i t h i n  t h e  f e t a l  t i s s u e s .  G u e n t h e r  a n d  M a n n e r i n g  (1977) 
i n v e s t i g a t e d  t h e  t r a n s p l a c e n t a l  t r a n s f e r  O f  p h e n o b a r b i t o n e .  T h e y  
f o u n d  l e v e l s  o f  p h e n o b a r b i t o n e  i n  t h e  f e t a l  l i v e r  t o  b e  a s  h i g h  a s  i n
t h e  m a t e r n a l  l i v e r .  I n d u c t i o n  o f  m O n O O x y g e n a s e  a c t i v i t y  w a s  s e e n  i n
t h e  m a t e r n a l  l i v e r  b u t  n o t  t h e  f e t a l  l i v e r .
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The fold induction seen in the fetal hepatocytes is very much larger 
than that seen in the adult liver. Shirkey (1977) saw an
approximately 10-fold induction of hepatic 7-ethoxycoumarin 
0-deethylase activity in adult rat after a dose of 25mg/kg
3-methylcholanthrene daily for 4 days. However, the level of
7-ethoxycoumarin 0-deethylase activity in the fetal hepatocytes from
the untreated animals is very low in comparison with control adult 
hepatocytes. Induction with p-naphthoflavone gives rise to values 
for 7-ethoxycoumarin 0-deethylase activity which are similar in 
magnitude to those seen in control adult hepatocytes (Fry and
Bridges, 1980).
Measurement of the cytochrome P-450 concentration in the microsomal 
preparation from the g^naphthoflavone pretreated animals gave a value 
of 0.067nmol/mg of microsomal protein. This is much lower than the 
concentration normally seen in untreated adult rat hepatic 
microsomes. Fahl et al. (1979) determined a value of O.54nmol/mg of 
microsomal protein for control adult hepatic microsomes. Since the 
7-ethoxycoumarin 0-deethylase activity in the hepatocytes from 
g-naphthoflavone pretreated animals is approximately equal to that 
seen in hepatocytes prepared from control adult rats, the cytochrome 
P-450 species induced in the fetal hepatocytes must he a specific 
form with a high rate of dééthylation of 7-ethoxycoumarin. The 
reduced CO-hinding maximum measured in the fetal microsomes from the 
p-naphthoflavone-pretreated rats was at 448nm, indicating a 
similarity to the effect of p-naphthoflavone on adult liver (Wiehel, 
1980).
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The results Of the inhibition study suggest that the increase in 
7-ethôxycôumarin 0-deethylase activity seen in fetal hepatocytes from 
animals treated with 3-methylcholanthrene, ArOchlOr and
P-naphthOflavone is the result of the appearance Of a form of 
cytochrome P-450 that is strongly inhibited by a-naphthoflavOne. 
PhenObarbitOne-treated animals show little increase in 
7-ethOxycoumarin 0-deethylase activity and an activation Of 
7-ethOxycOumarin 0-deethylase activity by a-naphthoflavOne. 
Activation by a-naphthOflavOne is discussed in section 3.12.4.
An increased inhibition Of 7-ethOxycOumarin 0-deethylase activity by 
metyrapOne was seen in fetal hepatocytes from animals treated with 
3-methylcholanthrene and ArOchlOr compared to those from the 
untreated animals. This may be related to the increase in inhibition 
Of 7-ethôxycôumarin 0-deethylase activity by metyrapOne seen in the 
cultured fetal hepatocytes as compared tO fresh fetal hepatocytes 
(see section 3.3*2). The significance Of this finding is not clear.
The Ouchterlony immunoprécipitation studies suggest that 3-methyl- 
cholanthrene, ArOchlOr and g-naphthoflavone all induce a type Of 
cytochrome that immunOprecipitates with the antibody raised to 
cytochrome P-448 as described in table 4.4. The cytochrome producing 
the immunoprécipitation may be identical to that purified frOm the 
p-naphthoflavone treated adults Or there may be Only be certain 
antigenic determinants common to both, giving rise to
crOss-reactivity. The concomitant induction Of Other forms Of 
cytochrome P-450 cannot, however, be discounted and the relative 
importance of the particular form interacting with the P-448 
antiserum, in the metabolism of 7-ethOxycoumarin, is unknown.
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MicrôsOmal fractions of fetal liver from ^-naphthoflavone-treated 
animals give the most immunoprécipitation with the P-448 antiserum. 
These are followed hy ArOchlor and 3-methylchOlanthrene and then the 
control micrOsOmal fraction. This order Of degree Of
immunoprécipitation is in agreement with the Order Of induction of 
7-ethoxycOumarin 0-deethylase hy the three compounds as shown in 
table 4.2.
T h e s e  r e s u l t s ,  h o w e v e r ,  d o  n o t  a l l o w  a n y  c o n c l u s i o n s  t O  b e  d r a w n  o n  
t h e  a b s e n c e  o f  e i t h e r  c y t o c h r o m e  P-450 o r  P-452 f r o m  a n y  O f  t h e  f e t a l  
h e p a t i c  m i c r O s O m a l  p r e p a r a t i o n s  s i n c e  t h e  t i t r e s  o f  t h e  a n t i s e r a  a r e  
u n k n o w n  a n d  a  l o w  t i t r e  O f  a n t i s e r u m  w i l l  r e d u c e  t h e  s e n s i t i v i t y  O f  
t h e  a s s a y .
Figure 4.2 shows an SDS polyacrylamide gel Of fetal liver microsomal 
fractions from untreated, Arochlor-treated, p-naphthoflavone-treated 
and 3-methylcholanthrene-treated animals. No evidence Of changes in 
the polypeptide profiles Of the various micrOsOmal fractions was 
Obtained. However, the total cytOchrOme P-450 concentration present 
in the fetal microsomal fractions from the treated and untreated 
fetal livers is very low. Thus, it is possible that SDS 
polyacrylamide gel electrophoresis is nOt a sensitive enough 
technique to detect changes in the profiles Of the fetal cytochrome 
P-450 isoenzymes on pretreatment with ArOchlor, p-naphthoflavone and 
3-methylcholanthrene.
The immunocytochemistry studies demonstrated staining Of untreated 
fetal rat liver with antibody raised to cytochrome P-450. 
P-NaphthOflavOne-treatment gave rise to a small increase in
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c y t ô c h r ô m e  P-450 c o n c e n t r a t i o n  a n d  3- m e t h y l c h o l a n t h r e n e  a  s m a l l  
d e c r e a s e  i n  c y t O c h r O m e  P-450 c o n c e n t r a t i o n .  T h e s e  d i f f e r e n c e s  m a y  h e  
a  r e s u l t  O f  t h e  t r e a t m e n t  O r  m a y  h e  d u e  t o  i n t e r - i n d i v i d u a l  
v a r i a t i o n .  A r ô c h l ô r - t r e a t e d  f e t a l  l i v e r  s h o w e d  m u c h  t h e  s a m e  a m o u n t  
O f  s t a i n i n g  a s  u n t r e a t e d  f e t a l  l i v e r .
Staining with the anti-P-448 was barely detectable in the untreated 
fetal livers. More staining was evident in the fetal liver from the 
3-methylcholanthrene-treated animal, more still in the fetal liver 
from the Arôchlôr-treated animal and most in the fetal liver from the 
p-naphthOflavone-treated animal. These results correlate well with
the extent Of induction of 7-ethôxycôumarin 0-deethylation seen as a 
result of the various treatments.
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TABLE 4.6 SUMMARY OE THE EFFECTS OF MATERNAL ADMINISTRATION OF
3-METHYLCHOLANTHRENE, AROCHLOR AND p-NAPHTHOFLAVONE ON 
FETAL HEPATIC PHASE I METABOLISM
TREATMENT FOLD INDUCTION % INHIBITION RESULTS OF STAINING
OF 7-ECOD BY ANF IMMUNO- WITH
DIFFUSION ANTI-P-448
none
3-MC
Arochlor
BNF
66.2
858
1460
15
92.2
98.6
97.9
++
++
+++
++
+++
+ - 7-ethoxyco\jinarin 0-deethylase 
3-MC - 3-methylcholanthrene 
ANF - a-naphthoflavone 
BNF - p-naphthoflavone
The effects of maternal administration of 3-methylcholanthrene, 
Arochlor and P-naphthoflavone are summarised in table 4.6. There is 
good correlation between all the parameters studied. The results 
indicate that the induction of 7-ethoxycoumarin 0-deethylase activity 
is accompanied by the appearance in the fetal liver of a new 
cytochrome P-450 species which is inhabitable by a-naphthoflavone and 
immunOprecipitable by anti-P-448. Thus, there are similarities 
between the form induced by these compounds in the fetal and adult 
rat. Other studies are needed to demonstrate whether they are truly 
identical.
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A number Of studies have investigated the nature Of fetally and 
neonatally induced cytochrome P-450. Atlas et al, (l977) 
investigated induction in the fetal and neOnatal rabbit. They found 
that biphenyl 4-hydrôxylatiôn was induced 2-fOld by 3-methyl­
cholanthrene treatment in the fetus and in the neOnate but did not 
Occur after 50 days Of age. Aryl hydrocarbon hydroxylase and 
biphenyl 2-hydrOxylase were also induced by 3-methylchOlanthrene in 
the fetus and neonate but not after 12 days Of age. 7-Ethôxycôumarin 
0-deethylase cOuld be induced by 3-methylcholanthrene-treatment in 
the fetus and neOnate but decreased 40 -60 percent On 3-methyl-
cholanthrene-treatment at all ages beyOnd 10 days. The fetally and 
neOnatally induced activities were associated with increases in an 
electrophoretic band of 51,000 molecular weight, sensitivity to 
inhibition by a-naphthoflavone and the absence Of a hypsOchrômic 
shift.
Norman et al. (1978) investigated the effect Of transplacentally 
administered 2,3,7,8-tetrachlorOdibenzO-p-diOxin On neonatal rabbit 
cytochrome P-450. They found Only One form Of cytOchrOme P-450 was 
induced in the neonatal rabbits. This form was identified as fOrm 6. 
It showed good metabolism Of benzo(a)pyrene and 7-ethOxyresOrufin and 
was strongly inhibited by a-naphthoflavone. However, in the adult 
the major form of cytochrome P-450 inducible by 2,3,7,8-tetrachlOrO- 
dibenzo-p-dioxin is form 4. Form 6 is Only a minor induced form. 
Thus it would appear that the nature Of the cytOchrOmes P-450 induced 
by tetrachlorodibenzô-p-diôxin in the neOnate and adult are 
different.
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G u e n t h e r  a n d  N e h e r t  (1978) e x a m i n e d  t h e  i n d u c i h i l i t y  O f  t h r e e  
c y t o c h r o m e  P-450 s p e c i e s  b y  t e t r a c h l o r o d i b e n z o - p - d i o x i n  i n  t h e  f e t a l  
r a t .  T h e y  f o u n d  t h a t  a  c y t O c h r O m e  P-450 s p e c i e s  O f  m o l e c u l a r  w e i g h t  
51,000 w a s  p o o r l y  i n d u c e d  o n  d a y s  18, 20 a n d  22 o f  g e s t a t i o n .  T h e  
c y t o c h r o m e  P-450 s p e c i e s  O f  m o l e c u l a r  w e i g h t  54,000 s h o w e d  s O m e  
i n d u c t i o n  O n  d a y s  18 a n d  20 w i t h  b e t t e r  i n d u c t i o n  a p p a r e n t  o n  d a y  22 
O f  g e s t a t i o n .  T h e  f o r m  o f  c y t o c h r o m e  P-450 h a v i n g  a m o l e c u l a r  w e i g h t  
O f  56,000 s h o w e d  g O O d  i n d u c t i o n  O n  d a y s  18, 20 a n d  22 O f  g e s t a t i o n .  
T h i s  i n d i c a t e s  t h a t  i n d u c t i o n  i s  a f f e c t e d  b y  f e t a l  a g e  a n d  t h a t  t h e  
c y t o c h r o m e  P-450 s p e c i e s  m o s t  s u s c e p t i b l e  t o  i n d u c t i o n  i s  t h a t  O f  
m o l e c u l a r  w e i g h t  5 6 , 0 0 0 .
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CHAPTER FIVE : FINAL DISCUSSION
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5.1 The Effects Of Culture On HepatOcyte Drug Metabolising Activity:
A Comparison Of Fetal and Adult Hepatocytes
The activity Of 7-ethôxycôumarin 0-deethylase and 7-ethôxyresôrufin 
0-deethylase increases during the culture Of fetal hepatocytes. On 
the basis of inhibitor studies in fresh and cultured cells, this 
increase is probably the result Of a change in the nature of the 
cytochrome P-450 responsible for the metabolism Of 7-ethôxycôumarin 
and 7-ethôxyresôrufin. From the results of the protein synthesis 
inhibitor study, the increase in activity appears to require de nOvO 
synthesis Of protein. Thus it would appear that the increased 
7-ethôxycôumarin 0-deethylase and 7-ethOxyresOrufln 0-deethylase 
activities is a result Of de nôvô synthesis of a new form of 
cytochrome P-450. On the basis of the measurement of the total 
cytochrome P-450 concentration, the new cytOchrOme appears to have a 
higher specific activity for the metabolism of 7-ethôxycôumarin and 
7-ethôxyresôrufin than that Originally present in the freshly 
isolated cells.
Much work has been carried Out on the stability Of the cytOchrOme 
P-450 drug metabolising system in cultured adult hepatocytes. 
Guzelian et al. (1977) found that in the first 24-48 hour period Of 
culture, the total amount Of cytOchrOme P-450 present in the cells 
dropped to 20 percent Of its original level. They postulated that 
damage in preparation and broad deterioration Of the cells were not 
responsible for the loss Of cytochrome P-450 as Other enzyme 
activities remained stable after this culture period.
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Pry et al. (1980) investigated the nature ôf the cytochrome P-450 
present in freshly isolated adult rat hepatOcytes and hepatocytes 
cultured for four days. They found a decrease in the form of 
cytochrome P-450 induced hy phenOharhitOne and inhibited by
metyrapone and SKP-525A and an increase in the type Of cytOchrOme
induced by benzo(a)anthracene and inhibited by (X-naphthoflavOne. 
Pahl et al. (1979) showed a .similar effect in adult rat hepatocytes 
cultured fOr 10 days. Pahl et al. (1979) attempted to characterise 
the cytochrome(s) which became predominant in the cultured cells. An 
increase in the rate Of metabolism of benzo(a)pyrene per nmOle Of 
cytochrome was observed with a change in the metabolite pattern to 
resemble that Of 5-methylchOlanthrene-induced liver. This indicated 
that a P-448 type Of cytochrome was appearing in the cultured cells. 
However, the reduced CO-binding difference spectrum gave an
absorbance maximum at 450.7nm suggesting that although similar to 
cytochrome P-448 the cytochrome apparent in the cultured cells was 
not the same.
Lake and Paine (1982), investigating a number Of drug metabolising 
activities in cultured adult rat hepatocytes found a 5-fOld increase 
in 7-ethOxyresOrufin 0-deethylase activity between 24 and 48 hours in 
culture. Ethylmorphine H-demethylase showed a reduction of 
approximately forty percent in activity Over the same period and 
7-ethOxyoOumarin 0-deethylase fell by thirty percent between 24 and 
48 hours and by a further thirty percent at 96 hours in culture. 
This is, however, in contrast to the wOrk Of BenfOrd and Bridges 
(personal communication) who found 7-ethOxycOumarin 0-deethylase 
activity decreased initially but then increased after 96 hours in
culture to an activity slightly higher than in freshly isolated
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cells. There is, currently, nO explanation for this discrepancy.
It has been suggested that the cytOchrOme P-450 appearing in the 
adult cultured cells is the result Of selective degradation of most 
Of the forms normally present in liver cells, allowing One usually 
minor form to become dominant (Pahl et al., 1979). Sirica et al. 
(1980), however, suggested that the cytOchrOme may be a new fOrm 
expressed as a result Of culture conditions.
Thus, there appear to be similarities between the changes taking 
place in the adult and fetal hepatocytes during culture. The 
appearance Of the new cytOchrOme appears to take place much more 
slowly in the adult hepatocytes compared with the fetal hepatocytes. 
There are indications On the basis Of a-naphthoflavone inhibition and 
preferred substrates that the cytOchrOme appearing in the adult and 
fetal hepatocytes are similar. HOwever, One difference between the 
cultured adult and fetal hepatocytes is in the inhibition Of 
7-ethOxycOumarin 0-deethylase activity by metyrapOne. Petal 
hepatocytes cultured for 24 and 48 hours show an increase in 
inhibition by metyrapone as compared to freshly isolated cells.
On culture, however, adult cells show a marked decrease in inhibition 
by metyrapone (Bridges and Pry, 1978), This difference may be due to 
differences in the stability Of the constitutive cytOchrOme P-450 Or 
to differences in the inhibition characteristics Of the cytochrome 
P-450 appearing in the cultured hepatocytes.
A number Of investigations On the maintenance Of cytochrome P-450 in 
adult rat hepatocyte cultures have been carried Out. Paine et al. 
(1979) maintained cytOchrOme P-450 levels in cultured adult rat
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hepatocytes hy supplementing the culture medium with nicotinamide.
Villa et al. (l980) found that addition Of certain substituted
pyridines to adult hepatocyte cultures prevented the loss Of
cytochrome P-450. The most potent Of these was metyrapOne.
However, there is nO evidence that maintenance of cytochrome P-450 in 
cultured adult rat hepatocytes prevents the appearance Of the new
fOrm(s) Of cytochrome. Lake and Paine (1982) found that metyrapone, 
while maintaining the P-450 type Of cytochrome, induced those
activities associated with the P-448 type of cytochrome. This aspect 
has not been investigated in fetal hepatocytes.
5.2 The Usefulness Of Fresh and Cultured Petal Hepatocytes for 
Investigations Of Petal Drug Metabolism 
Petal hepatocytes represent a useful in vitro system fOr the
investigation of fetal drug metabolism. They enable a long
incubation period with substrate, avoid problems encountered in the 
preparation of subcellular fractions and unphysiOlOgical levels Of 
cOfactors need nOt be added. However, this study has demonstrated 
that culture of fetal hepatocytes can affect the nature Of their 
phase I metabolism. The changes which take place are dependent On 
fetal age. Thus, studies in cultured fetal hepatocytes Of drug
metabolism involving phase I reactions may provide erroneous 
information regarding fetal drug metabolism in vivO.
Petal hepatic glucurOnyl transferase and sulphotransferase activities 
appear to be less affected by culture. Thus, cultures Of fetal 
hepatocytes may prove more useful in investigating phase II 
metabolism. However, this area requires further study before
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investigations of fetal phase II metabolism are routinely carried out 
in cultured fetal hepatocytes.
Freshly isolated cells can be incubated with substrate for 3 hours. 
The results of this study suggest that the cytochrome P-450 
composition of freshly isolated fetal hepatocytes may more closely 
resemble that in vivo than does the cytochrome P-450 composition of 
cultured fetal hepatocytes, indicating that freshly isolated fetal 
hepatocytes may be a more useful system for investigating fetal drug 
metabolism. However, the change in the nature of cytochrome P-450 
seen on culturing may already be occurring in the freshly isolated 
cells. Thus, if fresh or cultured fetal hepatocytes are to be used 
for fetal drug metabolism studies, the nature of the culture induced 
changes must first be fully understood.
5.3 The Nature of Fetal Drug Metabolism
This study has produced evidence of 7-ethoxycoumarin 0-deethylase 
activity at day 17 of gestation. There is a slow rise in the 
7-ethoxycoumarin 0-deethylase activity between day 17 of gestation 
and birth at day 22. 7-Ethoxyresorufin 0-deethylase has also been 
shown to be present in the fetus - at day 20 of gestation. Phase II 
metabolism in the form of 7-hydroxycoumarin glucuronyl transferase 
and sulphotransferase has also been shown to occur in the 20 day old 
fetus. In all cases the metabolism is very low in comparison with 
adult rat.
In freshly isolated hepatocytes from fetuses of 19-22 days of 
gestational age, there is only a very small amount of inhibition of 
7-ethoxycoumarin 0-deethylase activity by a-naphthoflavone. This
1 4 2
suggests that cytochrome P-448-type activity is very low in the 
fetus. The concentration of cytochrome P-450 is low in the fetus in 
comparison to the adult. The Soret peak, however, of the CO-hound 
cytochrome shows a peak at 450nm the same as is seen in the adult 
rat.
The presence in the fetal liver of material immunoprecipitable by 
anti-cytochrome P-450 and anti-cytochrome P-448 has been demonstrated 
by Ouchterlony double diffusion immunoprécipitation and by 
immunocytochemistry. Cytochrome P-450 is clearly present in the 
fetal liver and is quite widely distributed. Cytochrome P-448, 
however, is present only in trace amounts and is barely detectable in 
the stained liver sections.
The fetal liver appears to be particularly susceptible to the effect 
of certain enzyme inducers (3-methylcholanthrene, Arochlor and 
P-naphthoflavone) and particularly unresposive to others 
(phenobarbitone) in comparison to the adult. Induction gives rise to 
an increased concentration of the type of cytochrome P-450 which is 
immunoprecipitated by the antibody raised to a 
p-naphthoflavone-induced adult rat cytochrome P-450. The
fetally-induced cytochrome is also inhibitable by a-naphthoflavone. 
The type of cytochrome(s) induced in the fetus by P-naphthoflavone, 
Arochlor and 3-methylcholanthrene appear to be similar to those 
induced in the adult by these compounds.
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5.4 Future ¥ork
This study has investigated the nature of fetal drug metabolism and 
the nature of culture-induced changes is drug metabolism in fetal 
hepatocytes. Many aspects of these two areas remain to be studied. 
Studies on many different substrates are required to elucidate 
further the nature of the fetal cytochrome(s) P-450 and the nature of 
culture induced changes in drug metabolism. Since drug metabolising 
activity in the fetus is low, the development of sensitive drug 
metabolism assays is required. Further investigation of phase II
metabolism is also required, both with respect to different 
substrates and with respect to other pathways of phase II metabolism 
apart from glucuronidation and sulphation.
Further investigation of the nature of the cytochrome(s) P-450 in 
fetal tissues and fresh and cultured hepatocytes may be made easier 
by the increasing availability of antibodies raised to various 
purified forms. These antibodies allow detection of small quantities 
of cytochrome, in small samples.
Purification of the fetal cytochromes P-450 would enable a full 
characterisation to be carried out. Peptide mapping and amino acid 
composition studies could be carried out on the purified cytochromes 
enabling a comparison to be made between the fetal and adult 
cytochromes. However, currently used cytochrome P-450 purification 
techniques would not produce a sufficiently high yield of purified 
cytochrome to make the purification of fetal cytochromes practical. 
Modification of this technique is required before progress may be 
made in this direction.
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